[
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.01",
        "Artifact name": "Trial Master File Plan",
        "Definition / Purpose": "To describe how records for the trial will be managed and stored during and after the trial, including study-specific processes and documentation for archiving and destruction. To include TMF filing structure to be used. May include TMF content list, filing structure and chain of custody records. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Document Transfer Documentation\nEvidence of Quality Review\nRequest to Lock TMF\nTrial Master File Plan\nTrial Master File Index  \nTrial Master File Report\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "5.5.7",
        "Unique ID Number": 1,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.02",
        "Artifact name": "Trial Management Plan",
        "Definition / Purpose": "To describe overall strategy for timelines, management and conduct of the trial and typically makes reference to other artifacts. Artifact can include details on contingency plan covering details for site start up planning.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Clinical Development Plan\nProject Management Plan\nTrial Management Plan\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 2.2,
        "Unique ID Number": 2,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.03",
        "Artifact name": "Quality Plan ",
        "Definition / Purpose": "To describe the operational techniques and activities undertaken within the quality management system to verify that the requirements for quality of the trial-related activities have been fulfilled. Relevant parts may include, but not be limited to, a plan written for internal oversight of study quality management, an audit plan, data verification steps, serious breach assessments; also includes escalation in the event of a quality issue being identified and all corrective and preventative actions determined. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Quality Documentation\nQuality Plan \nQuality Report    \n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 5.1,
        "ISO 14155 Reference (Device Studies)": "7.11                    9.1 a\n",
        "Unique ID Number": 3,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.04",
        "Artifact name": "List of SOPs Current During Trial",
        "Definition / Purpose": "To document which standard operating procedures (SOPs) and which versions were in effect for the duration of the trial and trial-specific procedures created for the trial. To include sponsor and third party SOPs. This artifact does not include the SOPs themselves. May include SOP waivers to document and describe study-specific deviation from a named SOP or working procedure and the rationale for the deviation, when applicable.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "List of SOPs Current During Trial\nSOP Waivers\nSOP Deviations\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1.1",
        "Unique ID Number": 4,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.05",
        "Artifact name": "Operational Procedure Manual",
        "Definition / Purpose": "To describe trial-related processes not covered by formal standard operating procedures. Includes manuals given to sites for ISFs and vendor study-specific manuals as well as any study related tools provided to investigator sites not subject to IRB/IEC approval. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Operational Procedure Manual\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "5.1.1",
        "Unique ID Number": 5,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.06",
        "Artifact name": "Recruitment Plan",
        "Definition / Purpose": "To describe the planned subject enrolment/recruitment goals during the trial, including contingency plans. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Recruitment Plan\nRecruitment Progress\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 5.6,
        "Unique ID Number": 6,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.07",
        "Artifact name": "Communication Plan",
        "Definition / Purpose": "To describe communication strategy and plans between trial stakeholders, including communication escalation procedures/steps. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Communication Plan",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 7,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.08",
        "Artifact name": "Monitoring Plan",
        "Definition / Purpose": "To describe how monitoring will be implemented during the trial, including strategy for source data verification and risk based monitoring (if applicable). Artifact can include any trial level evidence of plan execution including, but not limited to: plan, reports, checklists, etc.  Note: Individual Monitoring Visit Reports are filed in zone 5.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Monitoring Plan \nRisk Based Monitoring Plan\nRisk Based Monitoring Evidence\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.18.3\n5.18.7",
        "ISO 14155 Reference (Device Studies)": "6.7\n7.3\n9.2.4.1 ",
        "Unique ID Number": 8,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.09",
        "Artifact name": "Medical Monitoring Plan",
        "Definition / Purpose": "To describe how medical surveillance of trial subjects will be assured during the trial. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Medical Monitoring Plan\nMedical Contact Report\nMedical Monitoring Decisions ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": 5.16,
        "ISO 14155 Reference (Device Studies)": 6.11,
        "Unique ID Number": 9,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.10",
        "Artifact name": "Publication Policy",
        "Definition / Purpose": "To describe the policy for publishing the trial results if publication policy is not captured within the protocol.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Publication Policy",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 6.15,
        "Unique ID Number": 10,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.11",
        "Artifact name": "Debarment Statement",
        "Definition / Purpose": "To verify whether the applicant or any of its principals is currently debarred, suspended, proposed for debarment, or declared ineligible to receive federal awards; whether within the past three years the applicant, or any of its principals, has been convicted of or had a civil judgment rendered against it for, or been indicted for, commission of fraud or certain criminal offenses; and whether the applicant has had any federal award terminated for cause or default in the past three years. Often part of the site qualification process, however, can account for situations which might arise during the course of the study, especially relevant for long-term trials.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Debarment Statement\nRestricted Party Lists",
        "Core or Recommended for inclusion": "Recommended",
        "Artifact name in v1.3 EDM Reference Model": "Debarment Certification",
        "Unique ID Number": 11,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "#2 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.12",
        "Artifact name": "Trial Status Report",
        "Definition / Purpose": "Routine trial status progress report generated by the sponsor or 3rd Party and distributed to trial stakeholders.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Status Report",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "5.18.4 (g)",
        "Unique ID Number": 12,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Date Generated"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.13",
        "Artifact name": "Investigator Newsletter",
        "Definition / Purpose": "To inform investigative staff of common implementation issues and of the progress of the trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Investigator Newsletter",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 13,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.14",
        "Artifact name": "Audit Certificate",
        "Definition / Purpose": "Documentation to confirm that an audit was performed (does not contain the audit report).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Audit Certificate\nList of Audits\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.4.4",
        "ISO 14155 Reference (Device Studies)": "E3.4         7.11 e                  9.1\nD13 h",
        "Artifact name in v1.3 EDM Reference Model": "Audit Certificates Report",
        "Unique ID Number": 14,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 27,
        "Process Name": "Conduct Audit(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Issue Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.15",
        "Artifact name": "Filenote Master List",
        "Definition / Purpose": "To provide a consolidated list/index of file notes generated during the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote Master List",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 15,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.16",
        "Artifact name": "Risk Management Plan",
        "Definition / Purpose": "To describe the potential hazards associated with the trial, including an assessment of the likelihood of those hazards occurring and resulting in harm. The Risk Management Plan is intended to include the risks to participant safety in relation to the IMP and all other risks related to the design and methods of the trial, including risks to participant safety and rights, as well as reliability of results. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Risk Management Plan\nRisk Assessment\nRisk Log\n",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "6.2   5.6.2 c\n5.6.2 d\n7.8.1\n9.2.3 h\n9.2.6 c\n7.5.1\n7.10\nAnnex H",
        "Unique ID Number": 236,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.17",
        "Artifact name": "Vendor Management Plan",
        "Definition / Purpose": "To describe the overall management strategy for third party vendors used to conduct trial-related activities. May include assignment of responsibilities for third party vendor oversight, performance indicators, monitoring activities and schedules, issue escalation and resolution process, technology and documentation transfer and business continuity plan. Artifacts providing evidence of plan execution including, but not limited to: reports, checklists, etc. and other records demonstrating oversight of a specific third party vendor should be filed in the appropriate artifacts in Zone 09",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Vendor Management Plan",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "9.3 \n",
        "Unique ID Number": 237,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.18",
        "Artifact name": "Roles and Responsibility Matrix",
        "Definition / Purpose": "To identify range and distribution of tasks and responsibilities; may define internal assignment and all external parties; covers GCP as well as business process; often part of the Contractual Agreement (09.02.03).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Roles and Responsibility Matrix ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.2.2\n5.7",
        "ISO 14155 Reference (Device Studies)": "6.1\n9.2.1a",
        "Unique ID Number": 181,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.19",
        "Artifact name": "Transfer of Regulatory Obligations ",
        "Definition / Purpose": "To specify the transfer of regulatory obligations from sponsor to each Affiliate/CRO/Vendor and may include other agreements. A sponsor may transfer responsibility for any or all of the obligations set forth in this part to another entity. Any such transfer shall be described in writing. If not all obligations are transferred, the writing is required to describe each of the obligations being assumed by the alternate entity. If all obligations are transferred, a general statement that all obligations have been transferred is acceptable. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Transfer of Regulatory Obligations ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.2.2\n5.7",
        "ISO 14155 Reference (Device Studies)": 9.3,
        "Unique ID Number": 247,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.01,
        "Section Name": "Trial Oversight",
        "Artifact #": "01.01.20",
        "Artifact name": "Operational Oversight",
        "Definition / Purpose": "Documentation to show evidence of sponsor oversight of study, as well as any key decisions taken and the supporting rationale. Records demonstrating oversight of a specific third party should be filed in the appropriate artifacts in Zone 09.\n",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Operational Oversight Plan\nOperational Oversight Evidence \n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 248,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "04 First Monitoring Visit",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.02,
        "Section Name": "Trial Team",
        "Artifact #": "01.02.01",
        "Artifact name": "Trial Team Details",
        "Definition / Purpose": "To define trial roles, contact details and structure of the trial team - both sponsor and third parties; optionally this may include full and initials-only signature of all team members, role-to-role transition documents, organogram and/or team joining/leaving dates.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Team Details\nTransition Evidence\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "2.8\n5.7",
        "ISO 14155 Reference (Device Studies)": "E.1.28\nE.2.26     6.1        \n9.2.1 a\n9.2.1 g     \nD.13e",
        "Unique ID Number": 16,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 7,
        "Process Name": "Secure Resources / People",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.02,
        "Section Name": "Trial Team",
        "Artifact #": "01.02.02",
        "Artifact name": "Trial Team Curriculum Vitae",
        "Definition / Purpose": "To document qualifications and eligibility of sponsor trial team members. Documentation for third party trial team members should be filed in Zone 09.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Team Curriculum Vitae",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": 2.8,
        "ISO 14155 Reference (Device Studies)": "9.2.1g \n6.1",
        "Unique ID Number": 17,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 7,
        "Process Name": "Secure Resources / People",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.03,
        "Section Name": "Trial Committee",
        "Artifact #": "01.03.01",
        "Artifact name": "Committee Process",
        "Definition / Purpose": "To describe the purpose and mode of operation/manner of working of the Independent Trial Committee, which may be established by the sponsor to assess at intervals the progress of a clinical trial the safety data and the critical efficacy endpoints and to recommend to the sponsor whether to continue, modify or stop a trial. To describe in advance the decision-making process of the Committee that will evaluate key trial events (e.g. endpoints). \n\nCommittee Types may include but not limited to: DMC, DSMB, National, Steering, Scientific, Internal DMC, Device, Dose Escalation, Safety Evaluation, Adjudication, Clinical Events Coordination. These may be used as sub-artifacts or metadata. Applies to all Committee artifacts",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Charter\nCommittee Process \n\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.2",
        "ISO 14155 Reference (Device Studies)": 6.11,
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Unique ID Number": 18,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.03,
        "Section Name": "Trial Committee",
        "Artifact #": "01.03.02",
        "Artifact name": "Committee Member List",
        "Definition / Purpose": "To document the current composition of a trial committee. Can be part of the Charter.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member List",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.2",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Unique ID Number": 19,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.03,
        "Section Name": "Trial Committee",
        "Artifact #": "01.03.03",
        "Artifact name": "Committee Output",
        "Definition / Purpose": "To document any agreements or significant decisions regarding trial conduct, protocol violations, adverse event reporting, to include minutes, reports, notifications, recommendations from a trial committee. Can be applicable to interim and final analyses.\n\n",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Correspondence\nCommittee Data Package\nCommittee Minutes\nCommittee Report\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "1.25\n5.5.2",
        "ISO 14155 Reference (Device Studies)": 6.11,
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Unique ID Number": 20,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 31,
        "Process Name": "Manage Subject Risk / Resolve Trial Issues",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.03,
        "Section Name": "Trial Committee",
        "Artifact #": "01.03.04",
        "Artifact name": "Committee Member Curriculum Vitae",
        "Definition / Purpose": "To document qualifications and eligibility of the Committee Member to provide assessments, at set intervals, the progress of a clinical trial, of the safety data and the critical efficacy endpoints and to recommend to the sponsor whether to continue, modify or stop a trial. To include updates.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member Curriculum Vitae\nCommittee Member Medical License\nCommittee Member Training Evidence\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.2",
        "ISO 14155 Reference (Device Studies)": "6.1\n6.11",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Unique ID Number": 249,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.03,
        "Section Name": "Trial Committee",
        "Artifact #": "01.03.05",
        "Artifact name": "Committee Member Financial Disclosure Form",
        "Definition / Purpose": "To certify that no financial arrangements with a Committee Member have been made where study outcome could affect compensation; that the Committee Member has no proprietary interest in the tested product; that the Committee Member does not have a significant equity interest in the sponsor of the covered study, that the Committee Member has not received significant payments of other sorts; and/or disclosure of specified financial arrangements and any steps taken to minimize the potential for bias.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member Financial Disclosure Form",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.2",
        "ISO 14155 Reference (Device Studies)": "E.1.33\nE.2.30      5.6.2 d\n6.11\n9.2.1 e\n10.2 c\n",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Unique ID Number": 250,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.03,
        "Section Name": "Trial Committee",
        "Artifact #": "01.03.06",
        "Artifact name": "Committee Member Contract",
        "Definition / Purpose": "To document agreement of trial requirements between sponsor or 3rd Party and Committee Member.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member Contract\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.2",
        "ISO 14155 Reference (Device Studies)": 6.9,
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Unique ID Number": 251,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.03,
        "Section Name": "Trial Committee",
        "Artifact #": "01.03.07",
        "Artifact name": "Committee Member Confidentiality Disclosure Agreement",
        "Definition / Purpose": "A document between the sponsor and the Committee Member that defines the terms and basic criteria to assure that the party (or parties) receiving confidential information will maintain confidentiality and will not use that information for any purpose other than that described in the Agreement. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Committee Member Confidentiality Disclosure Agreement",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.2",
        "ISO 14155 Reference (Device Studies)": "E.1.13                     E.1.33     6.9 9.   2.1.a     9.2.1 d \n10.2.c\n",
        "Artifact name in v1.3 EDM Reference Model": "(If committee type is  appropriate) Data Monitoring Committee",
        "Unique ID Number": 252,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.04,
        "Section Name": "Meetings",
        "Artifact #": "01.04.01",
        "Artifact name": "Kick-off Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation made available for attendees of the trial kick-off meeting, including attendance sheets. Does not include Investigator Meeting content.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Kick-off Meeting Agenda\nKick-off Meeting Attendance Sheet\nKick-off Meeting Presentation Materials\nKick-off Meeting Minutes\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 24,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.04,
        "Section Name": "Meetings",
        "Artifact #": "01.04.02",
        "Artifact name": "Trial Team Training Material",
        "Definition / Purpose": "Trial-relevant training materials , including use of specialized systems.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Team Training Material\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.4.1",
        "ISO 14155 Reference (Device Studies)": "9.2.4.2 c\n7.3\n7.6",
        "Unique ID Number": 25,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 26,
        "Process Name": "Manage Project / Manage People",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.04,
        "Section Name": "Meetings",
        "Artifact #": "01.04.03",
        "Artifact name": "Investigators Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation made available for attendees of the investigator meeting(s). Includes meeting minutes or questions and answers (Q&A), attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Investigators Meeting Agenda \nInvestigators Meeting Attendance Sheet\nInvestigators Meeting Minutes\nInvestigators Meeting Presentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.1.2\n4.2.4",
        "Unique ID Number": 26,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.04,
        "Section Name": "Meetings",
        "Artifact #": "01.04.04",
        "Artifact name": "Trial Team Evidence of Training",
        "Definition / Purpose": "To document completion of study-specific trial team training, including certification or evidence of training (attendance sheets). Includes EDC training. Does not include each individual's education, training and experience to perform his/her role. This should be documented in the company learning management system.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Team Training Attendance Sheet\nTrial Team Training Certificate\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": 2.8,
        "ISO 14155 Reference (Device Studies)": "9.2.1 \n",
        "Unique ID Number": 253,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Training Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.05,
        "Section Name": "General",
        "Artifact #": "01.05.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but are not limited to: letters, memo, electronic communications and faxes. Correspondence referring to general topics and/or topics across multiple zones may be filed with this zone",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E.2.11       9.2.3 b\n9.2.4.5 o\n10.6 h\n",
        "Unique ID Number": 27,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": "21 / Per content",
        "Process Name": "Manage Project / Report on Progress / Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.05,
        "Section Name": "General",
        "Artifact #": "01.05.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 28,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.05,
        "Section Name": "General",
        "Artifact #": "01.05.03",
        "Artifact name": "Other Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during any other internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Meeting Agenda\nOther Meeting Attendance Sheet\nOther Meeting Minutes\nOther Meeting Presentation Materials\n\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 29,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 1,
        "Zone Name": "Trial Management",
        "Section #": 1.05,
        "Section Name": "General",
        "Artifact #": "01.05.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone. Filenotes referencing general topics and/or topics across multiple zones may be  filed within this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 30,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.01",
        "Artifact name": "Investigator's Brochure",
        "Definition / Purpose": "To provide relevant and current clinical and non-clinical data on the investigational product(s) that is related to the study of the product(s) in human subjects. The Investigational Medicinal Product Brochure (IMPD) can additionally be filed here if held in the TMF.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Investigator's Brochure\nInvestigator's Brochure Addendum\nInvestigator's Brochure Extension\nInvestigator's Brochure Review and Approval\nInvestigator's Brochure Summary of Changes\nInvestigational Medicinal Product Documentation\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "7.1\n8.2.1\n8.3.1",
        "ISO 14155 Reference (Device Studies)": "E.1.1\nE.2.1        6.5\n7.5.1\nAnnex B\n6.3",
        "Unique ID Number": 31,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 2,
        "Process Name": "Develop Study Design / Study Conduct",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.02",
        "Artifact name": "Protocol ",
        "Definition / Purpose": "To describe the objective(s), design, methodology, statistical considerations and organization of a trial. Usually also gives the background and rationale for the trial, but these could also be provided in other protocol referenced documents. Includes Special Protocols. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol \nProtocol Review and Approval\nClinical Investigation Plan (Devices)\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "1.44\n8.2.2",
        "ISO 14155 Reference (Device Studies)": "E.1.2             4\n5.6.2.a\n5.6.4\n6.3\n6.4 \n7.1\n7.5.1\n10.6 b\n10.6 f\nAnnex A\n7.1\n7.8.2\nAnnex 1",
        "Artifact name in v1.3 EDM Reference Model": "Full Protocol (CSR component)\n",
        "Unique ID Number": 32,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 2,
        "Process Name": "Develop Study Design / Study Conduct",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.03",
        "Artifact name": "Protocol Synopsis",
        "Definition / Purpose": "A summary of the pertinent points of the protocol. A local language version may be translated from core (English) or produced in the country if required by local Regulatory Authorities or IRB/IEC",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Summary\nProtocol Synopsis\n\n",
        "Core or Recommended for inclusion": "Core",
        "Artifact name in v1.3 EDM Reference Model": "Synopsis (CSR component)",
        "Unique ID Number": 33,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.04",
        "Artifact name": "Protocol Amendment",
        "Definition / Purpose": "Subsequent versions of the original protocol as well as supporting documentation that may include description of change(s) to or formal clarification of a protocol. Includes justification for a non-substantial amendment, such as administrative changes",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Amendment\nProtocol Amendment Summary of Changes\nProtocol Amendment Review and Approval\nProtocol Amendment Synopsis\nProtocol Amendment  Administrative Changes\nJustification For a Non-Substantial Amendment\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "1.45\n8.3.2",
        "ISO 14155 Reference (Device Studies)": "E2.2        7.51           ",
        "Artifact name in v1.3 EDM Reference Model": "Protocol Amendment (CSR component)",
        "Unique ID Number": 34,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.05",
        "Artifact name": "Financial Disclosure Summary",
        "Definition / Purpose": "Summary documentation of compliance with financial disclosure reporting requirements, per company and/or local government policies. May include summaries, lists, other reports. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Financial Disclosure Summary",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 35,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 7,
        "Process Name": "Secure Resources / People",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.06",
        "Artifact name": "Insurance",
        "Definition / Purpose": "To document that compensation to subject(s) for trial-related injury will be available. May include policy and certificates, terms and conditions. Certificate is core, policy is recommended.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Insurance Policy\nInsurance Certificate\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.5",
        "ISO 14155 Reference (Device Studies)": "E.1.25     5.3\n5.6.2 j\n9.2.2 e",
        "Unique ID Number": 36,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.07",
        "Artifact name": "Sample Case Report Form ",
        "Definition / Purpose": "Blank forms / templates in paper form or e-Format to capture the data points of the protocol. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sample Case Report Form \nCRF Summary of Changes\nCRF Review and Approval\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.2\n8.3.2",
        "ISO 14155 Reference (Device Studies)": "E.1.25\nE.1.26\nE.1.27     6.6\n7.4.2\n7.4.3\nAnnex C\n",
        "Artifact name in v1.3 EDM Reference Model": "Sample CRF/eCRF",
        "Unique ID Number": 37,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.10",
        "Artifact name": "Report of Prior Investigations",
        "Definition / Purpose": "To include reports of all prior clinical, animal and laboratory testing of the device and shall be comprehensive and adequate to justify the proposed investigation. Can be in addition or instead of an Investigator Brochure for device trials.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Report of Prior Investigations\nRPI Addendum\nRPI Summary of Changes\nRPI Review and Approval",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 239,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 2,
        "Process Name": "Develop Study Design / Study Conduct",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.01,
        "Section Name": "Product and Trial Documentation",
        "Artifact #": "02.01.11",
        "Artifact name": "Marketed Product Material",
        "Definition / Purpose": "Materials available in the legal pharmacologic description of a drug or device, subject to detailed regulatory specifications, including approved chemical and proprietary names, description and classification, clinical pharmacology, approved indications and usage, contraindications, warnings, precautions, adverse reactions, drug abuse and dependence information, over dosage discussion, dosage and administration, formulations and appropriate references.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Package Insert\nSummary of Product Characteristics\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "7.1\n8.2.1\n8.3.1",
        "Unique ID Number": 254,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 2,
        "Process Name": "Develop Study Design / Study Conduct",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.02,
        "Section Name": "Subject Documentation",
        "Artifact #": "02.02.01",
        "Artifact name": "Subject Diary",
        "Definition / Purpose": "To document subject data captured by the subject and external to the CRF (blank forms / templates).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Diary\nSubject Diary Review and Approval\nSubject Diary Summary of Changes\n\n",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "Annex C.2.4.L",
        "Unique ID Number": 38,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.02,
        "Section Name": "Subject Documentation",
        "Artifact #": "02.02.02",
        "Artifact name": "Subject Questionnaire",
        "Definition / Purpose": "To capture specific subject related information through a series of questions (blank forms / templates)",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Questionnaire\nSubject Questionnaire Review and Approval\nSubject Questionnaire Summary of Changes\n\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 39,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 3,
        "Process Name": "Develop Study Design / Capture Subject Data",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.02,
        "Section Name": "Subject Documentation",
        "Artifact #": "02.02.03",
        "Artifact name": "Informed Consent Form",
        "Definition / Purpose": "To document that the appropriate written information (content and wording) has been given to subjects regarding the trial to support their ability to give fully informed consent and to document their consent to trial participation in writing. If applicable, must also include the child assent form (blank model / template). Please note that core template is trial level, the country template is country level and the site template is at the site level",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Consent to Release Information or HIPAA / Privacy\nInformed Consent Form\nICF Addendum\nICF QC Checklist\nICF Summary of Changes\nICF Review and Approval\nICF Summary of Changes\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.3\n8.3.2\n8.3.12",
        "ISO 14155 Reference (Device Studies)": "E.1.18\nE.2.3\nE.2.13     5.2            5.3             5.6.2 c\n5.6.2.d\n5.8.1 5.8.4\n7.8.1\n7.5.1\n8.6  9.2.2.b \n9.2.4.5.f    10.5      10.7.a    10.7.c    10.7.d     10.7.e",
        "Artifact name in v1.3 EDM Reference Model": "Informed Consent",
        "Unique ID Number": 40,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 17,
        "Process Name": "Recruit Subjects & Obtain Consent",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.02,
        "Section Name": "Subject Documentation",
        "Artifact #": "02.02.04",
        "Artifact name": "Subject Information Sheet",
        "Definition / Purpose": "To document information provided to subjects to support their decision about whether or not to participate in the trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Information Sheet\nSubject Information Sheet Addendum\nSubject Information Sheet Summary of Changes\nSubject Information Sheet Review and Approval\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.3\n8.3.2",
        "ISO 14155 Reference (Device Studies)": "E.1.18  5.6.2.c    5.6.2.d    5.8.4        7.8.1      9.2.2.b     ",
        "Unique ID Number": 41,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.02,
        "Section Name": "Subject Documentation",
        "Artifact #": "02.02.05",
        "Artifact name": "Subject Participation Card",
        "Definition / Purpose": "To be provided to the subject to carry to document trial participation (blank template).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Participation Card\nSubject Participation Card Summary of Changes\nSubject Participation Card Review and Approval\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.3\n8.3.2",
        "Unique ID Number": 42,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.02,
        "Section Name": "Subject Documentation",
        "Artifact #": "02.02.06",
        "Artifact name": "Advertisements for Subject Recruitment",
        "Definition / Purpose": "Materials used in clinical trial recruitment campaigns; approved by the IRB/IEC to ensure recruitment measures are appropriate and not coercive.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Advertisements for Subject Recruitment\nAdvertisements for Subject Recruitment Review and Approval\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.3\n8.3.2",
        "ISO 14155 Reference (Device Studies)": "E.1.18  5.6.2.c    5.6.2.d    5.8.4        7.8.1      9.2.2.b ",
        "Unique ID Number": 43,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.02,
        "Section Name": "Subject Documentation",
        "Artifact #": "02.02.07",
        "Artifact name": "Other Information Given to Subjects",
        "Definition / Purpose": "Materials provided to the subject to further assist with understanding the trial requirements or concepts; may include memory aids or retention materials.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Information Given to Subjects\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.3\n8.3.2",
        "ISO 14155 Reference (Device Studies)": "E.1.18 5.6.2.c    5.6.2.d    5.8.4        7.8.1      9.2.2.b ",
        "Unique ID Number": 44,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 17,
        "Process Name": "Recruit Subjects & Obtain Consent",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.03,
        "Section Name": "Reports",
        "Artifact #": "02.03.01",
        "Artifact name": "Clinical Study Report",
        "Definition / Purpose": "To describe final or interim results and interpretation of trial of any therapeutic, prophylactic, or diagnostic agent conducted in human subjects, in which all Clinical Study Report components are included, such as the clinical and statistical description, analyses, data listings, CRFs and summaries. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Clinical Investigation Report\nClinical Study Report\nClinical Study Report Synopsis\nIntegrated Clinical and Statistical Report\nInterim Clinical Study Report\nInterim Clinical Study Report Synopsis\nForm FDA 3654 (devices)\n\n",
        "Core or Recommended for inclusion": "Core ",
        "ICH Code": "1.13\n8.4.8",
        "ISO 14155 Reference (Device Studies)": "E.3.8      8.4          9.2.6   Annex D",
        "Artifact name in v1.3 EDM Reference Model": "Legacy CSR\nReport Body",
        "Unique ID Number": 45,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 40,
        "Process Name": "Report Data / Write Reports",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.03,
        "Section Name": "Reports",
        "Artifact #": "02.03.02",
        "Artifact name": "Bioanalytical Report ",
        "Definition / Purpose": "To present & summarize the relevant top line findings of the bioanalytical aspects of the interim or final analysis and may include PK analysis or reports.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Bioanalytical Report \nPharmacokinetic Report\n",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "8.6  9.2.2.b ",
        "Artifact name in v1.3 EDM Reference Model": "Type of Clinical Report",
        "Unique ID Number": 47,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 37,
        "Process Name": "Analyze Data / Final Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.04,
        "Section Name": "General",
        "Artifact #": "02.04.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E 2.11 9.2.3.c  9.2.4.5.o 10.6.h",
        "Unique ID Number": 48,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.04,
        "Section Name": "General",
        "Artifact #": "02.04.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 49,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.04,
        "Section Name": "General",
        "Artifact #": "02.04.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 50,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 2,
        "Zone Name": "Central Trial Documents",
        "Section #": 2.04,
        "Section Name": "General",
        "Artifact #": "02.04.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 51,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.01,
        "Section Name": "Trial Approval",
        "Artifact #": "03.01.01",
        "Artifact name": "Regulatory Submission",
        "Definition / Purpose": "A set of documents, along with required associated regulatory forms and correspondence, submitted to one or more regulatory agencies requesting approval to conduct the trial or for the purpose of notification, or requesting approval of changes to the trial documents or of any trial events that could adversely affect the safety of subjects, impact the conduct of the trial or alter the regulatory authority's approval/favorable opinion to continue the trial. Example Investigational New Drug Application (IND), Clinical Trial Application (CTA),  Investigational Device Exemption (IDE)\n\nThe submitted documents such as Investigator Brochure, Informed Consent Forms, etc. may or may not be filed as a complete Dossier within this Artifact, this is dependent on SOPs within your Organization.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Cover Letter\nList of Content Submitted\nReceipt of Acknowledgement\nRegulatory Submission\nReview and Approval of Regulatory Submission\n",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "E 2.11  8.2.2   9.2.2 g, 9.2.2.I\n9.4 a,b\n",
        "Unique ID Number": 52,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Submission Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.01,
        "Section Name": "Trial Approval",
        "Artifact #": "03.01.02",
        "Artifact name": "Regulatory Authority Decision",
        "Definition / Purpose": "A documented notification received from a regulatory authority stating that the Submission has been received and approved.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Condition Approval\nList of Content Approved\nRegulatory Authority Decision\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.9\n8.3.4",
        "ISO 14155 Reference (Device Studies)": "E.1.11\nE.2.5        7.1\n9.2.2G \n9.2.2.H \n",
        "Artifact name in v1.3 EDM Reference Model": "Letter of Authorization",
        "Unique ID Number": 53,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 14,
        "Process Name": "Secure Regulatory Approval",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Approval Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.01,
        "Section Name": "Trial Approval",
        "Artifact #": "03.01.03",
        "Artifact name": "Notification of Regulatory Identification Number",
        "Definition / Purpose": "Document identifying unique Identification (ID) number used to uniquely identify the trial or the trial level in that region, assigned by a regulatory agency  e.g. EU = EudraCT Number, FDA = IND Number, US Device = IDE Number.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Notification of Regulatory Identification Number",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 54,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 14,
        "Process Name": "Secure Regulatory Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Notification Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.01,
        "Section Name": "Trial Approval",
        "Artifact #": "03.01.04",
        "Artifact name": "Public Registration ",
        "Definition / Purpose": "Documentation related to registration of clinical trials in public registries such as ClinicalTrials.gov and to submission of results periodically during the study and at study completion. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Public Registration \nReceipt of Acknowledgement\n",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "Annex G 6 h \n5.4\n9.2.2j\nAnnex J F.2\n\n",
        "Unique ID Number": 55,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 11,
        "Process Name": "Notify Regulatory Agency of Trial",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Registration Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.02,
        "Section Name": "Investigational Medicinal Product",
        "Artifact #": "03.02.01",
        "Artifact name": "Import or Export License Application",
        "Definition / Purpose": "An application made to one or more regulatory agencies requesting a license to import or export the investigational product and clinical supplies.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Import License Application\nExport License Application\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 56,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Application Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.02,
        "Section Name": "Investigational Medicinal Product",
        "Artifact #": "03.02.02",
        "Artifact name": "Import or Export Documentation",
        "Definition / Purpose": "A document issued by a national government authorizing the importation or exportation of certain goods into its territory.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Import License\nExport License\nDevice Material Transfer Agreement,                               Device Material Transfer Application,                              Device Material Transfer Justification",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 57,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 6,
        "Process Name": "Secure Resources / Supplies",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.03,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "03.03.01",
        "Artifact name": "Notification of Safety or Trial Information",
        "Definition / Purpose": "Notification to Regulatory Authorities of any trial events that could alter the regulatory authority's approval/favorable opinion to continue the trial. Notifications may include, but are not limited to: Quarterly line listings, suspected unexpected serious adverse reactions (SUSARs), Unexpected Serious Adverse Device Events (USADE), Council for International Organizations of Medical Sciences (CIOMS), MedWatch, Analysis of Similar Events, Serious Breaches, cover letters and/or country-specific reporting forms.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Evidence of Distribution of Safety Information\nEvidence of Distribution of Trial Information\nNotification of Safety Information\nNotification of Trial Information\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.17",
        "ISO 14155 Reference (Device Studies)": "E.2.19      7.4     \n9.2.5.L 9.2.4.5.d 9.4 \n10.8                  \n7.4.2",
        "Unique ID Number": 58,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Notification Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.03,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "03.03.02",
        "Artifact name": "Regulatory Progress Report",
        "Definition / Purpose": "Reports concerning trial conduct, progress and status that are required to be periodically submitted to relevant regulatory authorities. This artifact is not intended to include safety reports required by regulatory authorities (these are covered under artifact 03.03.01).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Regulatory Progress Report\n",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "9.2.3 h\n9.2.6 d \n9.4 c",
        "Unique ID Number": 59,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 39,
        "Process Name": "Report Data / Provide Trial Updates",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Submission Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.03,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "03.03.03",
        "Artifact name": "Regulatory Notification of Trial Termination",
        "Definition / Purpose": "Document detailing the termination of a trial  whether upon completion or premature termination.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Regulatory Notification of Trial Termination\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.12, 5.21",
        "ISO 14155 Reference (Device Studies)": "E.3.7      8.3.\n9.2.6. \n",
        "Artifact name in v1.3 EDM Reference Model": "Notification of Discontinuation of Clinical Trial",
        "Unique ID Number": 60,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 32,
        "Process Name": "Close Site(s) / Notify Bodies",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Notification Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.04,
        "Section Name": "General",
        "Artifact #": "03.04.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E 2.11  9.2.3 b    9.2.4.5.o\n9.4         10.6.",
        "Unique ID Number": 61,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.04,
        "Section Name": "General",
        "Artifact #": "03.04.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 62,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.04,
        "Section Name": "General",
        "Artifact #": "03.04.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 63,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 14,
        "Process Name": "Secure Regulatory Approval",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 3,
        "Zone Name": "Regulatory",
        "Section #": 3.04,
        "Section Name": "General",
        "Artifact #": "03.04.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 64,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.01,
        "Section Name": "IRB or IEC Trial Approval",
        "Artifact #": "04.01.01",
        "Artifact name": "IRB or IEC Submission",
        "Definition / Purpose": "Documents describing the trial or changes/updates to the trial submitted to an IRB/IEC for approval, including recruitment and education materials and responses to questions from IRB/IEC to support a submission. Intended to include a list of attachments or table of contents of submission dossier/package. The submitted study documents such as Investigator Brochure, Informed Consent Forms, etc. may or may not be filed as a complete Dossier within this Artifact. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Acknowledgement of Submission Receipt\nIRB or IEC Submission\nRequest for Additional Information\nResponses\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.7\n8.3.3",
        "ISO 14155 Reference (Device Studies)": "E.1.9    5.6.3        7.1    9.2.2.h  10.4.C     ",
        "Unique ID Number": 65,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Submission Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.01,
        "Section Name": "IRB or IEC Trial Approval",
        "Artifact #": "04.01.02",
        "Artifact name": "IRB or IEC Decision",
        "Definition / Purpose": "Documentation received from IRB/IEC in response to submission indicating decision of the trial and any specifications or modifications. Records referenced by the approval (such as a Protocol that has been approved) should be filed elsewhere in the TMF, as appropriate, as long as there is identification of the approved record within the IRB/IEC letter. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Approval\nIRB or IEC Conditional Approval\nIRB or IEC Decision\nIRB or IEC Rejection\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.7\n8.3.3",
        "ISO 14155 Reference (Device Studies)": "E.1.9                   E 1.11\nE.2.4    5.6.3  5.6.4.e      5.6.4.a\n7.1        7.5.1.     \n9.2.2 h 9.2.3 b  9.2.4.5.o\n10.4 c\n9.2.4.5 o\n",
        "Unique ID Number": 66,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Approval Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.01,
        "Section Name": "IRB or IEC Trial Approval",
        "Artifact #": "04.01.03",
        "Artifact name": "IRB or IEC Composition",
        "Definition / Purpose": "Documentation that the IRB/IEC consists of a reasonable number of members who collectively have the qualifications and experience to review and evaluate the science, medical aspects and ethics of the proposed trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Composition\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.8",
        "ISO 14155 Reference (Device Studies)": "E.1.10  5.6.3",
        "Unique ID Number": 67,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.01,
        "Section Name": "IRB or IEC Trial Approval",
        "Artifact #": "04.01.04",
        "Artifact name": "IRB or IEC Documentation of Non-Voting Status",
        "Definition / Purpose": "Documentation verifying non-voting members of the IRB/IEC if the investigator or sub-investigator is on the IRB/IEC.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Documentation of Non-Voting Status",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "3.2.1",
        "ISO 14155 Reference (Device Studies)": "E.1.10  5.6.3",
        "Unique ID Number": 68,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.01,
        "Section Name": "IRB or IEC Trial Approval",
        "Artifact #": "04.01.05",
        "Artifact name": "IRB or IEC Compliance Documentation",
        "Definition / Purpose": "Documentation that the IRB/IEC is performing its function according to written operating procedures and is in compliance with GCP and applicable regulatory requirements. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Compliance Documentation\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "3.2.2\n3.4",
        "Unique ID Number": 69,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 15,
        "Process Name": "Secure Other Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.02,
        "Section Name": "Other Committees",
        "Artifact #": "04.02.01",
        "Artifact name": "Other Submissions",
        "Definition / Purpose": "A set of documents describing the trial or changes/updates to the trial submitted to a committee other than the IRB/IEC for approval. To include: Submissions and Correspondence \n\nThe submitted study documents such as Investigator Brochure, Informed Consent Forms, etc. may or may not be filed as a complete dossier within this artifact.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Approval Committee Submissions\n",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 70,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 15,
        "Process Name": "Secure Other Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Submission Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.02,
        "Section Name": "Other Committees",
        "Artifact #": "04.02.02",
        "Artifact name": "Other Approvals",
        "Definition / Purpose": "Approval documentation received from a committee other than the IRB/IEC in response to submission indicating approval/acknowledgement of trial specifications or modifications. To include: Submissions and Correspondence\n\nRecords referenced by the approval (such as a Protocol that has been approved) should be filed elsewhere in the TMF, as appropriate, as long as there is identification of the approved record within the committee letter or acknowledgement.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Approval Committee Decisions\n\n",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "10.4 e",
        "Unique ID Number": 71,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 15,
        "Process Name": "Secure Other Approvals",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Approval Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.03,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "04.03.01",
        "Artifact name": "Notification to IRB or IEC of Safety Information",
        "Definition / Purpose": "To assure the IRB/IEC are promptly notified of all findings (new, important information on serious adverse events and or safety concerns) that could adversely affect the safety of subjects, impact the conduct of the trial or alter the IRB/IEC's approval/favorable opinion to continue the trial.  Notifications/Communication may include but are not limited to - periodic safety line listings, USADEs, SUSARs, CIOMS, MedWatch, Analysis of Similar Events, cover letters and/or IRB/IEC-specific reporting forms. The records referenced in these notifications may be filed as appropriate in Zone 07.  May include IRB/IEC Acknowledgement of Receipt.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Acknowledgement of Receipt of Safety Information\nEvidence of Distribution of Safety Information\nNotification to IRB or IEC of Safety Information\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.17\n4.3.1\n4.4.3\n4.10.2",
        "ISO 14155 Reference (Device Studies)": "E.2.20  5.6.4\n9.2.5c\n10.4 d      10.8 c\n7.4.2",
        "Unique ID Number": 72,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Notification Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.03,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "04.03.02",
        "Artifact name": "IRB or IEC Progress Report",
        "Definition / Purpose": "Regular reports concerning trial conduct, other than safety reports, issued to the IRB/IEC by the sponsor/3rd Party and/or investigator.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Evidence of Distribution of Progress Report\nIRB or IEC Progress Report\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.19\n3.1.4\n3.3.8 \n4.4\n4.52\n4.54\n4.10.1\n4.10.2\n8.4.7",
        "ISO 14155 Reference (Device Studies)": "E.2.22  5.6.4 \n9.2.3 h     9.2.4.5.O\n10.4 \n10.8",
        "Unique ID Number": 73,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 39,
        "Process Name": "Report Data / Provide Trial Updates",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "06 Annual IRB / IEC Renewal",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "06 Annual IRB / IEC Renewal",
        "Dating Convention": "Submission Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.03,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "04.03.03",
        "Artifact name": "IRB or IEC Notification of Trial Termination",
        "Definition / Purpose": "Document detailing the termination of a trial  whether upon completion or premature termination.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRB or IEC Notification of Site Closure\nIRB or IEC Notification of Trial Termination\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.13\n4.12\n5.21",
        "ISO 14155 Reference (Device Studies)": "E.3.6   5.6.4\n8.3 b\n9.2.6 d\n10.4 f",
        "Unique ID Number": 74,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 32,
        "Process Name": "Close Site(s) / Notify Bodies",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Submission Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.04,
        "Section Name": "General",
        "Artifact #": "04.04.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E.2.11  9.2.3 b\n10.4 a",
        "Unique ID Number": 75,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.04,
        "Section Name": "General",
        "Artifact #": "04.04.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 76,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "R",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.04,
        "Section Name": "General",
        "Artifact #": "04.04.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 77,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 13,
        "Process Name": "Secure Ethical Approvals",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 4,
        "Zone Name": "IRB or IEC and other Approvals",
        "Section #": 4.04,
        "Section Name": "General",
        "Artifact #": "04.04.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 78,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.01,
        "Section Name": "Site Selection",
        "Artifact #": "05.01.01",
        "Artifact name": "Site Contact Details",
        "Definition / Purpose": "To document contact information for primary points of contact at the site (e.g. Principal Investigator, Institution Name, Trial Coordinator, Contracts Person, etc.).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Site Contact Details\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "E.1.8    A.1.4       ",
        "Unique ID Number": 79,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 7,
        "Process Name": "Secure Resources / People",
        "Trial Level Document ": "X",
        "Country/ Region Level Document": "X",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.01,
        "Section Name": "Site Selection",
        "Artifact #": "05.01.02",
        "Artifact name": "Confidentiality Agreement",
        "Definition / Purpose": "A document between the sponsor and an outside party (Investigator or Institution) that defines the terms and basic criteria to assure that the party (or parties) receiving confidential information will maintain confidentiality and will not use that information for any purpose other than that described in the Agreement. May also be present in the Clinical Trial Agreement",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Confidentiality Agreement",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": 1.16,
        "ISO 14155 Reference (Device Studies)": 6.9,
        "Unique ID Number": 80,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 7,
        "Process Name": "Secure Resources / People",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.01,
        "Section Name": "Site Selection",
        "Artifact #": "05.01.03",
        "Artifact name": "Feasibility Documentation",
        "Definition / Purpose": "To document site feasibility for the given protocol.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Feasibility Documentation\nFeasibility Questionnaire\nSite Selection Documentation\nTechnical Capabilities Questionnaire\n\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 5.6,
        "ISO 14155 Reference (Device Studies)": "6.8\n9.2.1\n9.2.4",
        "Unique ID Number": 81,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 5,
        "Process Name": "Develop Study Design / Feasibility & Site Evaluation",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.01,
        "Section Name": "Site Selection",
        "Artifact #": "05.01.04",
        "Artifact name": "Pre Trial Monitoring Report",
        "Definition / Purpose": "To document onsite visit to determine qualification of site to participate in the trial. For example may include the following documentation: EDC qualification, Confirmation Letters / Emails, site profile form.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Pre Trial Monitoring Report\nPre Trial Visit Confirmation Letter\nPre Trial Visit Follow Up Letter\nPre Trial Visit Waiver\nSite Selection Letter\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.19\n5.6",
        "ISO 14155 Reference (Device Studies)": "E.1.21      6.8\n9.2.1 b, 9.2.1 e \n9.2.4.3\n9.2.4.7\n10.3.a\n10.6 m\n10.6 n",
        "Unique ID Number": 82,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Visit Start Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.01,
        "Section Name": "Site Selection",
        "Artifact #": "05.01.05",
        "Artifact name": "Sites Evaluated but not Selected",
        "Definition / Purpose": "Documentation related to sites evaluated but not selected for the trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sites Evaluated but not Selected\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 5.6,
        "Unique ID Number": 83,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 7,
        "Process Name": "Secure Resources / People",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.01",
        "Artifact name": "Acceptance of Investigator Brochure",
        "Definition / Purpose": "To document that relevant and current scientific information about the investigational product has been provided to the investigator.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Acceptance of Investigator Brochure\nEvidence of Investigator Brochure Distribution\nEvidence of Reference Safety Information Distribution",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "8.2.1\n8.3.1",
        "Unique ID Number": 84,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.02",
        "Artifact name": "Protocol Signature Page",
        "Definition / Purpose": "To document investigator and sponsor agreement to the protocol.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Signature Page",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.2",
        "ISO 14155 Reference (Device Studies)": "7.5.1\n10.6 a\nAnnex A",
        "Artifact name in v1.3 EDM Reference Model": "Signature Page (Protocol component)",
        "Unique ID Number": 85,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.03",
        "Artifact name": "Protocol Amendment Signature Page",
        "Definition / Purpose": "To document investigator and sponsor agreement to the protocol amendment.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Amendment Signature Page",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.2",
        "ISO 14155 Reference (Device Studies)": "7.5.1       10.6.a       Annex A",
        "Artifact name in v1.3 EDM Reference Model": "Signature Page (Protocol component)",
        "Unique ID Number": 86,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.04",
        "Artifact name": "Principal Investigator Curriculum Vitae",
        "Definition / Purpose": "To document qualifications and eligibility of the Principal Investigator to conduct trial and/or provide medical supervision of subjects. To include updates, one-page CVs and biographical sketches.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Principal Investigator Affiliation Form\nPrincipal Investigator Biographical Sketch\nPrincipal Investigator Curriculum Vitae\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.10\n8.3.5",
        "ISO 14155 Reference (Device Studies)": "E.1.4\nE.2.6 5.6.2.e    \n9.2.1         10.2.a      10.2.b       D.13.c",
        "Artifact name in v1.3 EDM Reference Model": "Investigator CVs",
        "Unique ID Number": 87,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.05",
        "Artifact name": "Sub-Investigator Curriculum Vitae",
        "Definition / Purpose": "To document qualifications and eligibility of any sub-Investigators to conduct trial and/or provide medical supervision of subjects. Sub-Investigators include any individual member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical study trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). To include updates, one-page CVs and biographical sketches",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sub-Investigator Affiliation Form\nSub-Investigator Biographical Sketch\nSub-Investigator Curriculum Vitae\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.10\n8.3.5",
        "ISO 14155 Reference (Device Studies)": "E.1.5\nE.2.7        6.1       10.2.a    ",
        "Unique ID Number": 88,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.06",
        "Artifact name": "Other Curriculum Vitae",
        "Definition / Purpose": "To document qualifications and eligibility of site personnel other than the Principal Investigator or Sub-Investigators to conduct trial and/or provide medical supervision of subjects.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Other Affiliation Form\nOther Biographical Sketch\nOther Curriculum Vitae\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.10",
        "ISO 14155 Reference (Device Studies)": "E.1.6\nE.2.7        6.1         9.2.1\n9.2.4.3     10.2.a",
        "Unique ID Number": 89,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.07",
        "Artifact name": "Site Staff Qualification Supporting Information",
        "Definition / Purpose": "To document site staff qualifications not previously outlined on CVs. May include list of studies, publications, training certificates for specific examinations, ICH-GCP training, site GCP or trial licensure, medical licenses, Human Subjects Protection Training, etc. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "DEA License\nEvidence of Registration\nICH-GCP Evidence of Training\nIATA Certification\nMedical License\nMedical Qualification\nProfessional License\nSite Staff Qualification Supporting Information\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "9.2.1 g\n6.8",
        "Unique ID Number": 90,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.08",
        "Artifact name": "Form FDA 1572",
        "Definition / Purpose": "For IND trial, 1572 must be completed globally for FDA submission. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Form FDA 1572\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.6",
        "ISO 14155 Reference (Device Studies)": "E.1.12    10.3 b",
        "Unique ID Number": 91,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.09",
        "Artifact name": "Investigator Regulatory Agreement",
        "Definition / Purpose": "A regulatory statement from the investigator required by certain health authorities e.g. includes but is not limited to Qualified Investigator Undertaking form and Clinical Trial Site Information form required by Health Canada.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Clinical Trial Site Information Form\nInvestigator Regulatory Agreement\nQualified Investigator Undertaking Form\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.6",
        "ISO 14155 Reference (Device Studies)": "E.1.12      6.9    9.2.1.a",
        "Unique ID Number": 92,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.10",
        "Artifact name": "Financial Disclosure Form",
        "Definition / Purpose": "To document financial disclosures, certification documentation and conflicts of interest, which include but are not limited to: completed disclosure forms of financial interests and arrangements of clinical investigators ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Financial Disclosure Form\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.4",
        "ISO 14155 Reference (Device Studies)": "E.1.14\nE.1.33\nE.2.30 9.2.1 D\n9.2.2 F\n10.2 c\n ",
        "Artifact name in v1.3 EDM Reference Model": "Financial Disclosure Information",
        "Unique ID Number": 93,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.11",
        "Artifact name": "Data Privacy Agreement",
        "Definition / Purpose": "To document agreement between sponsor and Site Staff (e.g., national or regional data privacy requirements); often contained in Clinical Trial Agreement ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Privacy Agreement",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 94,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.12",
        "Artifact name": "Clinical Trial Agreement",
        "Definition / Purpose": "To document agreement of trial requirements between sponsor or 3rd Party and site/ PI. Includes indemnity unless separate document created. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Clinical Trial Agreement\nClinical Trial Agreement with Investigator\nClinical Trial Agreement with Investigator and Site\nClinical Trial Agreement with Site\nTermination Agreement",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.4\n8.2.6",
        "ISO 14155 Reference (Device Studies)": "E.1.12\nE.1.14      6.9\n9.2.1a\n9.2.2.F\n10.3 a",
        "Unique ID Number": 95,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.13",
        "Artifact name": "Indemnity",
        "Definition / Purpose": "To provide legal protection \"as required by country regulations\" in the event of an unforeseen adverse circumstance arising during the course of a clinical trial. May be in Clinical Trial Agreement",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Indemnity",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.4\n8.2.6",
        "ISO 14155 Reference (Device Studies)": "E 1.15\n5.6.2 j  9.2.2 e",
        "Unique ID Number": 96,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Country/ Region Level Document": "X",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.14",
        "Artifact name": "Other Financial Agreement",
        "Definition / Purpose": "To document agreement of trial requirements between other parties involved in the conduct of the trial. Includes indemnity unless separate document created.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Laboratory Agreement\nOther Financial Agreement\nPharmacy Agreement\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.4\n8.2.6",
        "ISO 14155 Reference (Device Studies)": "E.1.34     6.9           10.1",
        "Unique ID Number": 97,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 6,
        "Process Name": "Secure Resources / Supplies",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.17",
        "Artifact name": "IP Site Release Documentation",
        "Definition / Purpose": "To document approval for sites to receive drug supply / investigational product.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Site Release Checklist\nIP Site Release Documentation\nIP Site Release Notification\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "5.14.2",
        "Unique ID Number": 100,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.18",
        "Artifact name": "Site Signature Sheet",
        "Definition / Purpose": "To document delegation by the Principal Investigator of trial specific tasks to site personnel conducting the trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Delegation of Authority Log\nSite Signature Sheet\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.1.5\n8.3.24",
        "ISO 14155 Reference (Device Studies)": " E.1.7\nE.2.12     7.2\n9.2.1 e     9.2.2.d        \n9.2.4.4 b   9.2.4.5.b\n",
        "Unique ID Number": 101,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.19",
        "Artifact name": "Investigators Agreement (Device)",
        "Definition / Purpose": "Non-financial agreement between the sponsor and the investigator documenting the various responsibilities, as outlined in CFR Title 21 part 812 as well as ICH-E6 (if applicable), in which the investigator will comply.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Investigators Agreement (Device)",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "812.43c",
        "ISO 14155 Reference (Device Studies)": "E1.12        6.9                      9.2.1 a",
        "Unique ID Number": 240,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.02,
        "Section Name": "Site Set-up ",
        "Artifact #": "05.02.20",
        "Artifact name": "Coordinating Investigator Documentation",
        "Definition / Purpose": "Documentation to show the approval of a coordinating investigator for a specific region or group of investigators that is not already captured as another artifact for that investigator. Documentation related to a Country's National Coordinator when they are not participating as an Investigator in the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Coordinating Investigator Clinical Trial Agreement\nCoordinating Investigator Confidentiality Agreement\nCoordinating Investigator Curriculum Vitae\nCoordinating Investigator Documentation\nCoordinating Investigator Financial Disclosure Form\nCoordinating Investigator GCP Training\nCoordinating Investigator Indemnity\nCoordinating Investigator Medical License\nCoordinating Investigator Personal Data Consent\n",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 255,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 10,
        "Process Name": "Secure Resources / Committees",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.03,
        "Section Name": "Site Initiation",
        "Artifact #": "05.03.01",
        "Artifact name": "Trial Initiation Monitoring Report",
        "Definition / Purpose": "To document that trial procedures were reviewed with the investigator and the trial personnel and confirm the site meets requirements to begin trial participation. trial initiation can be conducted via an Investigator Meeting, visit at the site and/or other contact. May include confirmation letters/emails.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Trial Initiation Monitoring Report\nTrial Initiation Visit Confirmation Letter\nTrial Initiation Visit Follow Up Letter\nTrial Initiation Visit Waiver\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.20",
        "ISO 14155 Reference (Device Studies)": "E.1.22\nE.1.24     7.2      9.2.4.4  \n9.2.4.7\n",
        "Unique ID Number": 102,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 19,
        "Process Name": "Monitor Site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Visit Start Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.03,
        "Section Name": "Site Initiation",
        "Artifact #": "05.03.02",
        "Artifact name": "Site Training Material",
        "Definition / Purpose": "Training materials used to train the sites. Materials may be related to, but not limited to, Electronic Data Capture (EDC), Interactive Response Technology (IRT), Rater training. (Also includes training done after site initiation)",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Site Training Material\nQuick Reference Guide\nDevice Maintenance Documents                           Device Training Protocol",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.1.1",
        "ISO 14155 Reference (Device Studies)": "10.2 b",
        "Unique ID Number": 103,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.03,
        "Section Name": "Site Initiation",
        "Artifact #": "05.03.03",
        "Artifact name": "Site Evidence of Training",
        "Definition / Purpose": "\nTo document completion of site training by relevant site personnel. Documentation includes attendance and certification for training delivered which may include Electronic Data Capture (EDC), Interactive Response Technology (IRT), Rater training, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Site Evidence of Training\nSite Training Attendance Sheet\nSite Training Certificate\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.1.1",
        "ISO 14155 Reference (Device Studies)": "E.1.29  9.2.1 h\n",
        "Unique ID Number": 104,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Training Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.01",
        "Artifact name": "Subject Log",
        "Definition / Purpose": "To anonymously list all subjects including screened, screen failures and enrolled for the sponsor.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Consenting Tracker\nSubject Enrollment Log\nSubject Log\nSubject Screening Log \nSubject Visit Log\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.20\n8.3.22",
        "ISO 14155 Reference (Device Studies)": "E.2.23 7.5.2\n7.10",
        "Unique ID Number": 105,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 17,
        "Process Name": "Recruit Subjects & Obtain Consent",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.02",
        "Artifact name": "Source Data Verification ",
        "Definition / Purpose": "To document source data and associated verification activity ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Source Data Specification and Agreement\nSource Data Verification\nDevice Extracts                                                            \nSource Document Maps\n",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "E.1.23\nE.2.15   7.5.3    9.2.4.5.g\n10.6 c",
        "Unique ID Number": 106,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.03",
        "Artifact name": "Monitoring Visit Report",
        "Definition / Purpose": "To document site visits, monitoring trial conduct and compliance of the site, may include confirmation letters/emails.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Monitoring Visit Confirmation Letter\nMonitoring Visit Follow Up Letter\nMonitoring Visit Report\nMonitoring Visit Waiver\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.10",
        "ISO 14155 Reference (Device Studies)": "E.2.10 9.2.3 c     9.2.3 e  9.2.4.7\n",
        "Unique ID Number": 107,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 19,
        "Process Name": "Monitor Site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "04 First Monitoring Visit",
        "Dating Convention": "Visit Start Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.04",
        "Artifact name": "Visit Log",
        "Definition / Purpose": "To document monitoring visit dates and attendees.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Site Visit Log",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 108,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 19,
        "Process Name": "Monitor Site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Last visit Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.05",
        "Artifact name": "Additional Monitoring Activity",
        "Definition / Purpose": "To document additional sponsor and/or study-specific monitoring activities.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Additional Monitoring Activity\nNon-Routine Visit Report\nNon-Routine Visit Report Confirmation Letter\nNon-Routine Visit Report Follow Up Letter\nOversight Monitoring Visit Report\nOversight Monitoring Visit Report Confirmation Letter\nOversight Monitoring Visit Report Follow Up Letter\nSite Improvement Plan\nCo-Monitoring Visit Report\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 109,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 19,
        "Process Name": "Monitor Site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.06",
        "Artifact name": "Protocol Deviations ",
        "Definition / Purpose": "To document non-compliance/ deviations to the protocol. This may also be a consolidated list for a country filed at the country level or a consolidated list for the study filed at the study level.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Protocol Deviations \nProtocol Deviation Logs\nProtocol Deviation Report \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "3.3.8\n5.18.4",
        "ISO 14155 Reference (Device Studies)": "10.4 e \n10.6 g\n10.6 o",
        "Artifact name in v1.3 EDM Reference Model": "x Protocol Deviation Listing (component of CSR)",
        "Unique ID Number": 110,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 19,
        "Process Name": "Monitor Site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.07",
        "Artifact name": "Financial Documentation",
        "Definition / Purpose": "Includes all invoices, receipts, payment summaries relating to the trial",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Financial Documentation\nFinancial Summary Tracker\nInvoices\nPayments\nReceipts\n",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 111,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 24,
        "Process Name": "Manage Project / Manage Budget",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.08",
        "Artifact name": "Final Trial Close Out Monitoring Report",
        "Definition / Purpose": "To document trial activities are completed for site closure prior to trial completion. may include confirmation letters/emails.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Close Out Visit Confirmation Letter\nClose Out Visit Follow-Up Letter\nClose Out Visit Waiver\nFinal Trial Close Out Monitoring Report\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.4.5",
        "ISO 14155 Reference (Device Studies)": "E.3.5 9.2.4.6         9.2.4.7\n",
        "Unique ID Number": 112,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 34,
        "Process Name": "Close Site(s) / Close Site",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Visit Start Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.09",
        "Artifact name": "Notification to Investigators of Safety Information",
        "Definition / Purpose": "To assure investigators are promptly notified of all findings (new, important information on serious adverse events and or safety concerns) that could adversely affect the safety of subjects, impact the conduct of the trial or alter their IRB/IEC's approval/favorable opinion to continue the trial.  Notifications may include but are not limited to Safety line listings, SUSARs, CIOMS, MedWatch, Analysis of Similar Events, cover letters and/or country-specific reporting forms. \n ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Evidence of Safety Information Distribution\nNotification to Investigators of Safety Information\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.16.2\n5.17\n8.3.17-18 ",
        "ISO 14155 Reference (Device Studies)": "E.2.21 9.2.5\n",
        "Unique ID Number": 113,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Notification Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.10",
        "Artifact name": "Subject Identification Log",
        "Definition / Purpose": "To fully identify all subjects screened, screen failed and enrolled in the trial, with unique institution identifiers where relevant",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Identification Log",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.21\n8.4.3",
        "ISO 14155 Reference (Device Studies)": "E.2.24\nE.3.3   7.5.2",
        "Unique ID Number": 234,
        "Sponsor Document": "NO",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 17,
        "Process Name": "Recruit Subjects & Obtain Consent",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.11",
        "Artifact name": "Source Data ",
        "Definition / Purpose": "To document and confirm source data information at the Investigator site (i.e. medical records containing history of subjects).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Source Data \nSite Level Source Data Worksheets\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.13",
        "ISO 14155 Reference (Device Studies)": "E 2.13         E.2.14 7.5.3\n7.8.2\n10.6 c\n10.6 q    10.7 f  \n7.8.1",
        "Unique ID Number": 235,
        "Sponsor Document": "NO",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 18,
        "Process Name": "Complete Subject Study Visit",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.12",
        "Artifact name": "Monitoring Visit Follow-up Documentation",
        "Definition / Purpose": "To document site visit follow-up. Could be grouped with monitoring visit reports.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Monitoring Visit Follow-up Documentation",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E.1.24                     E 2.10 9.2.3.c   9.2.3.e  9.2.4.7",
        "Unique ID Number": 241,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 19,
        "Process Name": "Monitor Site(s)",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Visit Start Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.04,
        "Section Name": "Site Management",
        "Artifact #": "05.04.13",
        "Artifact name": "Subject Eligibility Verification Forms and Worksheets",
        "Definition / Purpose": "Eligibility forms for qualification of trial subjects, may include inclusion/exclusion criteria, lab reports, doctor notes and other qualifying data usually used by (site) staff to ensure subjects are eligible, per protocol, for the study.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Subject Eligibility Verification Forms and Worksheets",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "8.3.20\n8.3.22",
        "Unique ID Number": 256,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": 17,
        "Process Name": "Recruit Subjects & Obtain Consent",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.05,
        "Section Name": "General",
        "Artifact #": "05.05.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes. Should not include monitoring visit follow-up letter.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E.2.11  9.2.3 b   9.2.3.c    9.2.4.5.D\n10.6 e\n10.6 h",
        "Unique ID Number": 114,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.05,
        "Section Name": "General",
        "Artifact #": "05.05.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 115,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "R",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.05,
        "Section Name": "General",
        "Artifact #": "05.05.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 116,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 25,
        "Process Name": "Manage Project / Oversee Vendor(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 5,
        "Zone Name": "Site Management",
        "Section #": 5.05,
        "Section Name": "General",
        "Artifact #": "05.05.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 117,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 19,
        "Process Name": "Monitor Site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.01",
        "Artifact name": "IP Supply Plan",
        "Definition / Purpose": "To describe the following as they pertain to the IP: 1) quantity and packaging of active, placebo and/or if applicable, comparator or rescue supplies needed to fulfill the requirements of the trial protocol over the life of the trial, as well as blinding plan (if applicable) and 2) acceptable storage temperatures and conditions, storage times, reconstitution fluids and procedures and devices for product infusion. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Supply Plan\nPlacebo Justification Statement",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "2.13\n5.13.3 5.14.1",
        "ISO 14155 Reference (Device Studies)": "7.4.3\n7.9",
        "Unique ID Number": 118,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.02",
        "Artifact name": "IP Instructions for Handling",
        "Definition / Purpose": "To instruct on how the IP should be handled during transit and stored upon arrival at the distribution center, depot and/or trial site. Should address expectations for adequate and safe receipt, handling, storage, dispensing, retrieval of unused product from subjects and return of unused IP to the sponsor (or their delegate) If appropriate to the trial, includes preparation of the IP leading to administration and administration instructions. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Device User Manual     \nIP Directions for Use\nIP Instructions for Handling\nIP Manual\nPharmacy Manual\nDevice Packing Insert                                               Instruction For Use\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.13.2\n5.14.3\n8.2.14",
        "ISO 14155 Reference (Device Studies)": "10.2 b\nAnnex B.2.F              Annex I.7.C.3",
        "Unique ID Number": 119,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.03",
        "Artifact name": "IP Sample Label",
        "Definition / Purpose": "A sample of each IP label type (for every pack and every language) to be used in the trial; approval status must be clear. All stages of label text development are included within this artifact.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Master Label\nIP Sample Label\n\n",
        "Core or Recommended for inclusion": "Core ",
        "ICH Code": "5.13.1\n8.2.13",
        "ISO 14155 Reference (Device Studies)": "E.1.3    6.10.\nAnnex I.7\nAnnex B (B.2.g)",
        "Unique ID Number": 120,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.04",
        "Artifact name": "IP Shipment Documentation",
        "Definition / Purpose": "To record details of the shipment process including approval , requests, dispatch, tracking and receipts to/from a distribution center, depot and/or trial site. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Acknowledgement of Receipt\nApproval to Ship\nInvoice\nIP Shipment Documentation\nPackaging Order\nShipment Request Form\nTemperature (TempTale) Monitoring\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4\n8.2.15\n8.3.8",
        "ISO 14155 Reference (Device Studies)": "E. 1.16               E. 2. 8       7.9        9.2.2 C  9.2.3 a  9.2.4.5 n  10.6 K",
        "Unique ID Number": 121,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Shipment Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.05",
        "Artifact name": "IP Accountability Documentation",
        "Definition / Purpose": "To document records of the allocation of IP to/from a distribution center, depot, trial site and/or site to subject and the reconciliation of IP prior to return to the sponsor.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Drug Accountability Log\nIP Accountability Documentation\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4\n8.3.23\n8.4.1",
        "ISO 14155 Reference (Device Studies)": "E.1.16\nE.2.8\nE2.25\nE.3.1         7.9   \n8.3 a        9.2.2 C\n9.2.3  a     9.2.4.5.n\n10.6 k\n10.6 q            Annex I.7.C.1",
        "Unique ID Number": 122,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.06",
        "Artifact name": "IP Transfer Documentation",
        "Definition / Purpose": "To document the process and approval for the transfer of IP from one depot to another depot and/or from one site to another site (within or across protocols). Examples include sponsor approval for transfer and evidence of consultation with Qualified Person (QP). ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Evidence of IP Transfer\nIP Transfer Documentation\nIP Transfer Plan\nNotification of IP Transfer\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4 5.14.3",
        "Unique ID Number": 123,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Transfer Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.07",
        "Artifact name": "IP Re-labeling Documentation",
        "Definition / Purpose": "To document the plan for the re-labeling process to occur at the distribution center, depot and/or site and confirmation records that the re-labeling occurred. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Evidence of IP Relabeling\nIP Relabeling Documentation\nIP Relabeling Plan\nNotification of IP Relabeling\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4 5.14.3",
        "ISO 14155 Reference (Device Studies)": "6.10 \nAnnex I.7 C 2",
        "Unique ID Number": 124,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.08",
        "Artifact name": "IP Recall Documentation",
        "Definition / Purpose": "To document the plan for the recall process for the IP to occur at a distribution center, depot and/or site; will include confirmation records that the recall occurred.  ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Evidence of Recall\nIP Recall Documentation\nIP Recall Plan\nNotification of IP Recall\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4 5.14.3",
        "ISO 14155 Reference (Device Studies)": "9.2.2.D",
        "Unique ID Number": 125,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Recall Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.09",
        "Artifact name": "IP Quality Complaint Form",
        "Definition / Purpose": "To document or record an IP quality complaint. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Quality Complaint Form\nDevice Deficiency Report",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4",
        "ISO 14155 Reference (Device Studies)": "7.4.3                 9.1.a",
        "Unique ID Number": 126,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Complaint Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.10",
        "Artifact name": "IP Return Documentation ",
        "Definition / Purpose": "To record details of returns to/from a distribution center, depot and/or trial site.  Examples include courier documentation and packing/ inventory listing.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Acknowledgement of Return\nIP Return Documentation \nIP Return Form\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4\n8.2.15\n8.3.9",
        "ISO 14155 Reference (Device Studies)": "E.1.16\nE.3.2          7.9\n8.3 a               9.2.2.C\n9.2.3 a   9.2.45.n\n10.6 k\n7.4.3",
        "Unique ID Number": 127,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 33,
        "Process Name": "Close Site(s) / Reconcile Trial Materials",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Return Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.11",
        "Artifact name": "IP Certificate of Destruction",
        "Definition / Purpose": "To document the confirmation of destruction of IP at the end of a trial at a distribution center, depot and/or site . ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Certificate of Destruction\nIP Destruction Documentation\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.4 8.4.2",
        "ISO 14155 Reference (Device Studies)": "A.11,                   D.7 c,              E.1.17            , 10.6.k,             10.6.l",
        "Unique ID Number": 128,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 33,
        "Process Name": "Close Site(s) / Reconcile Trial Materials",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Destruction Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.01,
        "Section Name": "IP Documentation",
        "Artifact #": "06.01.12",
        "Artifact name": "IP Retest and Expiry Documentation",
        "Definition / Purpose": "To document the batch retesting/analyses of IP for a variety of reasons such as stability confirmation and expiry extension",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Expiry Extension\nIP Retest and Expiry Documentation\nStability Confirmation \nDevice Expiration Certificate\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.5",
        "Unique ID Number": 242,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.02,
        "Section Name": "IP Release Process Documentation",
        "Artifact #": "06.02.01",
        "Artifact name": "QP (Qualified Person) Certification",
        "Definition / Purpose": "To confirm that any IP from another country has been manufactured and checked in accordance with standards of Good Manufacturing Practices (GMP) at least equivalent to those laid down in Directive 91/356/EEC. Documents the technical release documentation including GMP certification and the name / address of the manufacturer. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "QP (Qualified Person) Certification",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "2.12\n5.13.1",
        "Unique ID Number": 129,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.02,
        "Section Name": "IP Release Process Documentation",
        "Artifact #": "06.02.02",
        "Artifact name": "IP Regulatory Release Documentation",
        "Definition / Purpose": "To document the regulatory IP release process.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Regulatory Release Documentation",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "2.12\n5.14.2",
        "ISO 14155 Reference (Device Studies)": "B.2.D",
        "Unique ID Number": 130,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": " ",
        "Dating Convention": "Release Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.02,
        "Section Name": "IP Release Process Documentation",
        "Artifact #": "06.02.03",
        "Artifact name": "IP Verification Statements",
        "Definition / Purpose": "Any certificate, license or other documentation that is required by a specific regulation to verify the quality, source, manufacture, ingredients or other aspect of investigational and/or control product. Examples include TSE certificate, Controlled IP storage, DEA 223 and GMP Manufacturers License.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Controlled IP Storage\nDEA 223 \nGMP Certificate\nGMP Manufacturers License\nGMP Statement\nIP Verification Statements\nManufacturing Authorization\nManufacturer's Certificate of Compliance\nTSE Certificate\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.15\n8.3.8 5.14.4",
        "ISO 14155 Reference (Device Studies)": "B.2.D",
        "Unique ID Number": 131,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.02,
        "Section Name": "IP Release Process Documentation",
        "Artifact #": "06.02.04",
        "Artifact name": "Certificate of Analysis ",
        "Definition / Purpose": "To document identity, purity and strength of the IP(s) to be used trial, in accordance with the specifications of the IP, including the acceptance limits and the actual results of the tests.  ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Batch Records\nCertificate of Analysis \nCertificate of Conformance\nDevice Quality Certification \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "2.12\n5.13.1\n8.2.16\n8.3.9",
        "Artifact name in v1.3 EDM Reference Model": "Certificate of Analysis ",
        "Unique ID Number": 132,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.03,
        "Section Name": "IP Allocation Documentation",
        "Artifact #": "06.03.01",
        "Artifact name": "IP Treatment Allocation Documentation",
        "Definition / Purpose": "To document the treatment allocation or device serial numbers for each subject; used if urgent unblinding or code break is needed or when interim or final unblinding occurs.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Treatment Allocation Documentation\nKit List\nRandomization Envelopes\nRandomization List\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.13.4\n8.2.17\n8.4.6",
        "ISO 14155 Reference (Device Studies)": "10.6 k             A.6.1.B",
        "Unique ID Number": 133,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.03,
        "Section Name": "IP Allocation Documentation",
        "Artifact #": "06.03.02",
        "Artifact name": "IP Unblinding Plan",
        "Definition / Purpose": "To describe the plan and procedures to be taken should the action of breaking the blind for an individual subject be urgently needed, or when interim or final unblinding occurs. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Unblinding Plan\nUnblinding Procedure\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.13.4\n8.2.17",
        "ISO 14155 Reference (Device Studies)": "E.1.20 7.8.1                        A 16 b    10.7.e",
        "Unique ID Number": 134,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.03,
        "Section Name": "IP Allocation Documentation",
        "Artifact #": "06.03.03",
        "Artifact name": "IP Treatment Decoding Documentation ",
        "Definition / Purpose": "To document the action of breaking the blind for an individual subject, urgently if needed, or when interim or final unblinding occurs. Treatment unblinding may be controlled by interactive response technology (IRT) and or manually using code break envelopes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Emergency Decoding Authorization Document\nIP Treatment Decoding Documentation \nTreatment Decoding Form\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.13.4 \n8.4.6",
        "Unique ID Number": 135,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 30,
        "Process Name": "Manage Subject Risk / Break Blind",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "08 Database Lock",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.04,
        "Section Name": "Storage",
        "Artifact #": "06.04.01",
        "Artifact name": "IP Storage Condition Documentation",
        "Definition / Purpose": "To document the unique storage conditions of the IP at the sponsor (if sponsor is distributing), distribution center, depot, trial site and in transit, if required by the available stability requirements of the IP. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IP Storage Condition Documentation\nTemperature Logs\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": " 5.13.2",
        "ISO 14155 Reference (Device Studies)": "D.6.1.5",
        "Unique ID Number": 136,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.04,
        "Section Name": "Storage",
        "Artifact #": "06.04.02",
        "Artifact name": "IP Storage Condition Excursion Documentation",
        "Definition / Purpose": "To record excursions for IP, from the acceptable pre-defined condition range either during transit or storage at a distribution center, depot and/or trial site. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Approval For Use (following temp excursion)\nIP Storage Condition Excursion Documentation\nTempTale Documentation\nTemperature Excursion Form \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.13.2",
        "Unique ID Number": 137,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.04,
        "Section Name": "Storage",
        "Artifact #": "06.04.03",
        "Artifact name": "Maintenance Logs ",
        "Definition / Purpose": "To record activities and times when quality of condition of IP, Non-IP, device and other trial supplies is assessed over period of use and any maintenance performed, including software logs and certificates of calibration. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Calibration Certificate\nCalibration Log\nMaintenance Logs",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.14.5",
        "ISO 14155 Reference (Device Studies)": " E.1.31\nE.2.28 9.2.4.5.p,            10.6 i",
        "Unique ID Number": 243,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.05,
        "Section Name": "Non-IP Documentation",
        "Artifact #": "06.05.01",
        "Artifact name": "Non-IP Supply Plan",
        "Definition / Purpose": "To describe the details and quantity of non-IP supplies needed to fulfill the trial protocol requirements over the life of the trial. May include but is not limited to, supplementary medication, pre-treatment, other prophylactic therapies, drug delivery supplies (IV tubing, syringes, etc.) and measurement tools such as thermometers, respirometers, etc. Artifact can include any evidence of plan execution including, but not limited to: plan, reports, checklists, etc.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Non-IP Supply Plan",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 2.13,
        "Unique ID Number": 138,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 23,
        "Process Name": "Manage Project / Manage Non-IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.05,
        "Section Name": "Non-IP Documentation",
        "Artifact #": "06.05.02",
        "Artifact name": "Non-IP Shipment Documentation",
        "Definition / Purpose": "To record details of the shipment of non-IP supplies needed to fulfill the trial protocol requirements to a distribution center, depot and/or site. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Acknowledgement of Receipt\nApproval to Ship\nInvoice\nNon-IP Shipment Documentation\nPackaging Order\nShipment Request Form\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "E.1.17\nE.2.9 9.2.2.a    9.2.2.d 9.2.4.4.a  9.2.4.4.d",
        "Unique ID Number": 139,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 23,
        "Process Name": "Manage Project / Manage Non-IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Shipment Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.05,
        "Section Name": "Non-IP Documentation",
        "Artifact #": "06.05.03",
        "Artifact name": "Non-IP Return Documentation ",
        "Definition / Purpose": "To inventory the returns of certain non-IP supplies needed to fulfill the trial protocol requirements to a distribution center, depot and/or site. Examples include courier documentation and packing/ inventory listing.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Acknowledgement of Return\nNon-IP Return Documentation \nNon-IP Return Form",
        "Core or Recommended for inclusion": "Recommended",
        "ISO 14155 Reference (Device Studies)": "E.1.17\nE.2.9 9.2.2.a    9.2.2.d 9.2.4.4.a  9.2.4.4.d",
        "Unique ID Number": 140,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 23,
        "Process Name": "Manage Project / Manage Non-IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Return Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.05,
        "Section Name": "Non-IP Documentation",
        "Artifact #": "06.05.04",
        "Artifact name": "Non-IP Storage Documentation",
        "Definition / Purpose": "To document the unique storage conditions of the Non-IP supplies at the sponsor (if sponsor is distributing), distribution center, depot, trial site and in transit, if required by the available stability requirements of the non-IP supplies. To record excursions for non-IP supplies, from the acceptable pre-defined condition range either during transit or storage at a distribution center, depot and/or trial site.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Non-IP Storage Documentation\nNon-IP Storage Condition Excursion Documentation",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 259,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 23,
        "Process Name": "Manage Project / Manage Non-IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.06,
        "Section Name": "Interactive Response Technology",
        "Artifact #": "06.06.01",
        "Artifact name": "IRT User Requirement Specification",
        "Definition / Purpose": "To document end user requirements from design and capabilities of an interactive response technology (IRT) such as Interactive Voice Response System (IVRS) or Interactive Web Response System (IWRS), included but not limited to screening, randomization or drug allocation. May also include technical aspects of the system development.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRT User Requirement Specification",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.3",
        "ISO 14155 Reference (Device Studies)": "A.8.B                 7.8.3   ",
        "Unique ID Number": 141,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.06,
        "Section Name": "Interactive Response Technology",
        "Artifact #": "06.06.02",
        "Artifact name": "IRT Validation Certification",
        "Definition / Purpose": "To confirm the validation status of the interactive response technology (IRT).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRT Validation Certification",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.3",
        "Unique ID Number": 142,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Certification Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.06,
        "Section Name": "Interactive Response Technology",
        "Artifact #": "06.06.03",
        "Artifact name": "IRT User Acceptance Testing (UAT) Certification",
        "Definition / Purpose": "To document the acceptability of the series of assessments of the IRT performed by key users of the system that are designed to show that the IRT has been correctly programmed and meets the requirements of the User Requirements Specification (URS). Minimally, the signature page and may include validation or other documentation.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRT UAT Certification\nIRT UAT Executed Scripts\nIRT UAT Sign Off\nIRT User Acceptance Testing (UAT) Certification\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.3",
        "ISO 14155 Reference (Device Studies)": "B.3.E",
        "Unique ID Number": 143,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Certification Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.06,
        "Section Name": "Interactive Response Technology",
        "Artifact #": "06.06.04",
        "Artifact name": "IRT User Manual",
        "Definition / Purpose": "To provide instructions and define the operational instructions for the IRT for the user.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRT Quick Reference Card\nIRT User Manual",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.3.3",
        "Unique ID Number": 144,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.06,
        "Section Name": "Interactive Response Technology",
        "Artifact #": "06.06.05",
        "Artifact name": "IRT User Account Management",
        "Definition / Purpose": "To capture account management details for all users who received access to the system; should include security role, data account granted, date account disabled",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "IRT User Account Management\nSummary of IRT Access Report",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 145,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IP",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.07,
        "Section Name": "General",
        "Artifact #": "06.07.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E 2.11  9.2.3 c             9.2.4.5 o            10.6 h\n",
        "Unique ID Number": 146,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.07,
        "Section Name": "General",
        "Artifact #": "06.07.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 147,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.07,
        "Section Name": "General",
        "Artifact #": "06.07.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "Unique ID Number": 148,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 6,
        "Zone Name": "IP and Trial Supplies",
        "Section #": 6.07,
        "Section Name": "General",
        "Artifact #": "06.07.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 149,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.01,
        "Section Name": "Safety Documentation",
        "Artifact #": "07.01.01",
        "Artifact name": "Safety Management Plan",
        "Definition / Purpose": "To describe the end-to-end process for the ongoing safety evaluation for the investigational product; includes data to be collected, reporting objectives and processes for a clinical trial. Plan may include but is not limited to: associated documents for quality management, safety database entry specifications and templates and/or coding guidelines.\n\nThis artifact may not be trial specific, thus may include a reference to appropriate SOP(s) or program/IP level plans. One example of where this artifact would be expected to be trial-specific is when a CRO performs this function for a single trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Reference Safety Information Approval Form\nSafety Management Plan\nSafety Reporting Plan\nSafety Reporting Templates\n",
        "Core or Recommended for inclusion": "Core ",
        "ICH Code": "2.2\n5.16.1",
        "ISO 14155 Reference (Device Studies)": "10.8 a\n7.4.1",
        "Unique ID Number": 150,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.01,
        "Section Name": "Safety Documentation",
        "Artifact #": "07.01.02",
        "Artifact name": "Pharmacovigilance Database Line Listing",
        "Definition / Purpose": "Listing of trial data for a single study trial used for a variety of safety evaluation of the investigational product purposes (e.g. Serious Adverse Events (SAE) case listings, database line listings, etc.). \n\nThis artifact may not be trial specific, thus may include a reference to program/IP level records. One example of where this artifact would be expected to be trial-specific is when a CRO performs this function for a single trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Annual Safety Report (ASR)\nDevelopment Safety Update Report (DSUR)\nPharmacovigilance Database Line Listing\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.16.1\n5.17.3",
        "ISO 14155 Reference (Device Studies)": "7.4.2",
        "Unique ID Number": 151,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.02,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "07.02.01",
        "Artifact name": "Expedited Safety Report",
        "Definition / Purpose": "To document unexpected serious adverse drug reactions and other safety information; submitted to regulatory authorities and IRBs/IECs.  Submission artifact is located in 03.03.01.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Expedited Safety Report",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.16.2\n5.17\n8.3.17-18",
        "ISO 14155 Reference (Device Studies)": "10.8 b\n7.4",
        "Unique ID Number": 152,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.02,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "07.02.02",
        "Artifact name": "SAE Report",
        "Definition / Purpose": "To organize critical data around a serious adverse event, adverse event and/or a laboratory abnormality as identified in the protocol. Reports may include, but are not limited to: specific investigator SAE report forms and supporting data, reporter correspondence, associated note-to-files, source documentation, case logs, narratives, case unblinding forms and/or safety database case printouts. \n",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "SAE Report\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.11\n8.3.16",
        "ISO 14155 Reference (Device Studies)": "E.2.17     7.4              9.2.4.5.k   9.2.4.5.L\n9.2.5 \n10.8 \nD 13 g",
        "Unique ID Number": 153,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.02,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "07.02.03",
        "Artifact name": "Pregnancy Report",
        "Definition / Purpose": "To organize critical data around a pregnancy that occurred whilst either the male or the female subject was participating in a clinical trial. Reporting forms and supporting data collected for pregnancy cases and their outcome. Reports may include but are not limited to specific regulatory forms and supporting data, reporter correspondence, associated note-to-files, source documentation, case logs, case unblinding form, narratives and/or safety database case printouts. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Pregnancy Report",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.11\n8.3.16",
        "Unique ID Number": 154,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Trial Level Document ": "x",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.02,
        "Section Name": "Trial Status Reporting",
        "Artifact #": "07.02.04",
        "Artifact name": "Special Events of Interest",
        "Definition / Purpose": "To organize critical data around a special event of interest, one that is of scientific and medical concern specific to the product or program. Usually requested by or submitted to Regulatory Agencies. Reports may include but are not limited to specific regulatory forms and supporting data, reporter correspondence, associated note-to-files, source documentation, case logs, narratives, case unblinding forms and/or safety database case printouts. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Special Events of Interest",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 155,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 29,
        "Process Name": "Manage Subject Risk / Manage Urgent Safety Measures",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.03,
        "Section Name": "General",
        "Artifact #": "07.03.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific, trial specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes. (Does not include program level communications.)",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E 2.11  9.2.3 c 9.2.4.5 O 10.6 h",
        "Unique ID Number": 156,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 28,
        "Process Name": "Manage Subject Risk / Report Safety Issue(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.03,
        "Section Name": "General",
        "Artifact #": "07.03.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific, trial specific documents developed for the purpose of tracking activities during the course of the trial.  (Does not include program level tracking information.)",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 157,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.03,
        "Section Name": "General",
        "Artifact #": "07.03.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related, trial specific meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material. (Does not include program level meeting material.)",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 158,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "21 / 28",
        "Process Name": "Manage Project / Report on Progress / Manage Subject Risk / Report Safety Issue(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 7,
        "Zone Name": "Safety Reporting",
        "Section #": 7.03,
        "Section Name": "General",
        "Artifact #": "07.03.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "10.8 e",
        "Unique ID Number": 159,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.01",
        "Artifact name": "Certification or Accreditation",
        "Definition / Purpose": "To document recognition and approval by an authorized accrediting body applying known acceptable standards, that the central or local facility is competent to perform required test(s) and support reliability of results; if applicable.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Certification or Accreditation\nCAP Certificate\nCLIA Certificate\nISO Certification\nOther Certification or Accreditation\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.12\n8.3.7",
        "ISO 14155 Reference (Device Studies)": "E.1.32\nE.2.29     6.1\n7.11                9.1\n9.2.1              9.2.4.5.o\n9.2.4.5.t",
        "Unique ID Number": 160,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.02",
        "Artifact name": "Laboratory Validation Documentation ",
        "Definition / Purpose": "To document through use of control data that a central or local laboratory can consistently and reproducibly report results that are reliable; may include but is not limited to reporting of calibration and control results for a research test parameter, antibody or pharmacokinetic testing that may be performed by an internal or external central or local laboratory; required if certification or accreditation is not available for the study test method.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Laboratory Validation Documentation \nLaboratory System Specifications\nLaboratory Kit Assembly Specifications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.12\n8.3.7",
        "ISO 14155 Reference (Device Studies)": "E.1.32\nE.2.29     6.1\n7.11                9.1\n9.2.1              9.2.4.5.o\n9.2.4.5.t",
        "Unique ID Number": 161,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.03",
        "Artifact name": "Laboratory Results Documentation ",
        "Definition / Purpose": "Summary listings or individual subject reports provided by the central or local laboratory or other testing facility, e.g. results of biochemical testing, histological examination.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Biochemical Testing\nImaging Uploads\nIndependent Rater Data\nLaboratory Results Documentation ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.12\n8.3.8",
        "ISO 14155 Reference (Device Studies)": "E.2.29",
        "Unique ID Number": 162,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 18,
        "Process Name": "Complete Subject Study Visit",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.04",
        "Artifact name": "Normal Ranges",
        "Definition / Purpose": "To define acceptable limits (where 95% of the population that a central or local facility serves will fall) for comparative interpretation that allow for medical decisions to be made; may be included in User Manual.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Normal Ranges",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.11\n8.3.6 ",
        "ISO 14155 Reference (Device Studies)": "E.1.30\nE.2.27 9.2.4.5.q",
        "Unique ID Number": 163,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 5,
        "Process Name": "Develop Study Design / Feasibility & Site Evaluation",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Effective Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.05",
        "Artifact name": "Manual",
        "Definition / Purpose": "To outline the procedures to be followed in the collection, handling and shipping of samples; may not be available for local facilities.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Imaging Manual\nLaboratory Manual\nManual\nOther Manual ",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "8.2.14",
        "Unique ID Number": 164,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.06",
        "Artifact name": "Supply Import Documentation",
        "Definition / Purpose": "To provide the necessary documentation required per country to allow for importation of supplies (non-drug / IP), may also include biological samples and related test material (kits, etc.)",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Biologic Supply Import\nBiosafety Statements           \nCustoms Statements                                                           \nProforma Invoices                                                             \nSecure Handling of Material and Data\nSupply Import Documentation\nSupply Import Licenses                                                     \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.15\n8.3.8",
        "Unique ID Number": 165,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IMP/Device",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.07",
        "Artifact name": "Head of Facility Curriculum Vitae",
        "Definition / Purpose": "To verify that the Head of Facility is suitably qualified to lead and oversee the management and reporting of results; may be included with Certification / Accreditation; may be found in the User Manual.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Head of Facility Curriculum Vitae\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "8.2.12\n8.3.7",
        "ISO 14155 Reference (Device Studies)": "E.1.32\nE.2.29     6.1\n7.11                9.1\n9.2.1              9.2.4.5.o\n9.2.4.5.t",
        "Unique ID Number": 166,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 25,
        "Process Name": "Manage Project / Oversee Vendor(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.01,
        "Section Name": "Facility Documentation",
        "Artifact #": "08.01.08",
        "Artifact name": "Standardization Methods  ",
        "Definition / Purpose": "To confirm that two or more central or local facilities can perform the same test / procedure and obtain consistent results; includes but may not be limited to cross-calibration of test methods between assays or facilities or phantom data or bioanalytical assay.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Analytical Method Report\nInterlaboratory Comparison Testing\nStandardization Methods  \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.12\n8.3.7",
        "Unique ID Number": 167,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.02,
        "Section Name": "Sample Documentation",
        "Artifact #": "08.02.01",
        "Artifact name": "Specimen Label",
        "Definition / Purpose": "To capture critical information about the collection of a sample; may include but is not limited to subject ID, date and time of collection, etc.; may be included in User Manual.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Specimen Label",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 168,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.02,
        "Section Name": "Sample Documentation",
        "Artifact #": "08.02.02",
        "Artifact name": "Shipment Records",
        "Definition / Purpose": "To provide relevant details for samples sent in any one shipment.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Specimen Shipment Records",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "8.2.15\n8.3.8",
        "Unique ID Number": 169,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IMP/Device",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Shipment Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.02,
        "Section Name": "Sample Documentation",
        "Artifact #": "08.02.03",
        "Artifact name": "Sample Storage Condition Log",
        "Definition / Purpose": "To monitor and track sample storage under the appropriate conditions.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sample Storage Condition Log",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "8.2.14",
        "Unique ID Number": 170,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 22,
        "Process Name": "Manage Project / Manage IMP/Device",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.02,
        "Section Name": "Sample Documentation",
        "Artifact #": "08.02.04",
        "Artifact name": "Sample Import or Export Documentation",
        "Definition / Purpose": "To provide the necessary documentation required per country to allow for importation/exportation of samples.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sample Import or Export Documentation\nSpecimen Export Documentation\nSpecimen Import Documentation\n\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.15\n8.3.8",
        "Unique ID Number": 171,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 6,
        "Process Name": "Secure Resources / Supplies",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.02,
        "Section Name": "Sample Documentation",
        "Artifact #": "08.02.05",
        "Artifact name": "Record of Retained Samples ",
        "Definition / Purpose": "To document location and identification of body fluid, tissue samples or genetic samples being held for possible future (re)testing; to include destruction records, when and if this occurs.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Biorepository\nDestruction Records\nDispatch Form\nInventory From Lab\nRecord of Retained Samples \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.25",
        "Unique ID Number": 172,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.03,
        "Section Name": "General",
        "Artifact #": "08.03.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E 2.11   9.2.3 c 9.2.4.5 o 10.6 h",
        "Unique ID Number": 173,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.03,
        "Section Name": "General",
        "Artifact #": "08.03.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 174,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.03,
        "Section Name": "General",
        "Artifact #": "08.03.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 175,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 6,
        "Process Name": "Secure Resources / Supplies",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 8,
        "Zone Name": "Central and Local Testing",
        "Section #": 8.03,
        "Section Name": "General",
        "Artifact #": "08.03.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 176,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.01,
        "Section Name": "Third Party Oversight",
        "Artifact #": "09.01.01",
        "Artifact name": "Qualification and Compliance",
        "Definition / Purpose": "To confirm that a third party meets all relevant criteria to fulfill a contractual obligation; may include a quality questionnaire, a visit report to qualify their capabilities, other documents that support capabilities.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Evidence of Third Party Qualification \nThird Party Audit Certificate",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "E.1.32\nE.2.29     6.1\n7.11                9.1\n9.2.1              9.2.4.5.o\n9.2.4.5.t",
        "Unique ID Number": 177,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.01,
        "Section Name": "Third Party Oversight",
        "Artifact #": "09.01.02",
        "Artifact name": "Third Party Curriculum Vitae",
        "Definition / Purpose": "To document qualifications and eligibility of Individual Third Party Trial Team Members; CVs, Questionnaires etc. including translators, for the project. Not intended to duplicate records filed in Zones 1 and 5 (sponsor & investigator).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Third Party Curriculum Vitae\n",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "E.1.32\nE.2.29     6.1\n7.11                9.1\n9.2.1              9.2.4.5.o\n9.2.4.5.t",
        "Unique ID Number": 257,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.01,
        "Section Name": "Third Party Oversight",
        "Artifact #": "09.01.03",
        "Artifact name": "Ongoing Third Party Oversight",
        "Definition / Purpose": "To confirm throughout the duration of a study that a third party continues to meet all relevant criteria to fulfill a contractual obligation.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Ongoing Third Party Oversight\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "5.2.2",
        "ISO 14155 Reference (Device Studies)": "J.2.f.15",
        "Unique ID Number": 258,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.02,
        "Section Name": "Third Party Set-up",
        "Artifact #": "09.02.01",
        "Artifact name": "Confidentiality Agreement",
        "Definition / Purpose": "To confirm by written legal agreement that key information between parties will be prevented from being inappropriately disclosed. May be included in another contractual agreement. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Third Party Confidentiality Agreement\n            \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": 1.16,
        "ISO 14155 Reference (Device Studies)": "E.1.13      6.9     9.2.1.a",
        "Unique ID Number": 178,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.02,
        "Section Name": "Third Party Set-up",
        "Artifact #": "09.02.02",
        "Artifact name": "Vendor Selection",
        "Definition / Purpose": "To identify how a third party was selected. May include details of other third parties short-listed, master vendor list and any assessments carried out prior to selection.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Vendor Evaluation \nVendor Decision \n",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 179,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 8,
        "Process Name": "Secure Resources / Vendors",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.02,
        "Section Name": "Third Party Set-up",
        "Artifact #": "09.02.03",
        "Artifact name": "Contractual Agreement",
        "Definition / Purpose": "To document by a written dated signed agreement between two or more parties that defines any arrangements on delegation and distribution of tasks and obligations (including financial obligations); critical components include service description and budget.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Authorization To Proceed\nBudget\nContract \nChange Order\nData Privacy Agreements\nIndemnification\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "1.17\n8.2.6",
        "ISO 14155 Reference (Device Studies)": "E.1.13      6.9     9.2.1.a",
        "Unique ID Number": 180,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 7,
        "Process Name": "Secure Resources / People",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.03,
        "Section Name": "General",
        "Artifact #": "09.03.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E 2.11  9.2.3 c \n9.2.4.5 o    10.6.h\n",
        "Unique ID Number": 182,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 25,
        "Process Name": "Manage Project / Oversee Vendor(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.03,
        "Section Name": "General",
        "Artifact #": "09.03.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 183,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.03,
        "Section Name": "General",
        "Artifact #": "09.03.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "9.2.4.2.c",
        "Unique ID Number": 184,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 25,
        "Process Name": "Manage Project / Oversee Vendor(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 9,
        "Zone Name": "Third parties ",
        "Section #": 9.03,
        "Section Name": "General",
        "Artifact #": "09.03.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 185,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.01,
        "Section Name": "Data Management Oversight",
        "Artifact #": "10.01.01",
        "Artifact name": "Data Management Plan ",
        "Definition / Purpose": "To identify the overall strategy for data management process for the trial; a compilation of documents that may include amendments/appendices but are not limited to: Completion Guidelines, Data Quality Plan, CRF Design Document, Database (build) Specification, Entry Guidelines, Database Testing..",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Management Plan ",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "6.6                        7.8.3.a",
        "Artifact name in v1.3 EDM Reference Model": "Data Management Plan",
        "Unique ID Number": 186,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.02,
        "Section Name": "Data Capture",
        "Artifact #": "10.02.01",
        "Artifact name": "CRF Completion Requirements",
        "Definition / Purpose": "To provide detailed instructions on how data points on each CRF are to be completed; how to enter on paper and if EDC, how to enter data into the system. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "CRF Completion Requirements",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "2.10\n4.9.1\n4.9.2",
        "ISO 14155 Reference (Device Studies)": "7.8.2",
        "Unique ID Number": 187,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "M",
        "Process Number": 3,
        "Process Name": "Develop Study Design / Capture Subject Data",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.02,
        "Section Name": "Data Capture",
        "Artifact #": "10.02.02",
        "Artifact name": "Annotated CRF ",
        "Definition / Purpose": "To assign variable names and attributes to the fields on the CRF and to link the variables to the tables within the database; may also be used as an aid for database programming on how to structure the database; use for data extraction; may be generated at the time of regulatory submission.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Annotated CRF \nAnnotated CRF Electronic Data Capture\nAnnotated CRF Study Data Tabulation Model (SDTM)\n",
        "Core or Recommended for inclusion": "Recommended",
        "ICH Code": 5.1,
        "ISO 14155 Reference (Device Studies)": "7.8.1      7.8.2   10.6 j",
        "Artifact name in v1.3 EDM Reference Model": "Annotated CRF",
        "Unique ID Number": 188,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 18,
        "Process Name": "Complete Subject Study Visit",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.02,
        "Section Name": "Data Capture",
        "Artifact #": "10.02.04",
        "Artifact name": "Documentation of Corrections to Entered Data ",
        "Definition / Purpose": "Any documentation used to query database discrepancies and to record approved corrections to the clinical trial database; may include self-evident corrections, global queries, SAE queries, laboratory queries and any other database queries generated.  Additionally, include any agreements per trial and site that trial personnel are permitted to perform without the need to issue a query to the investigator along with acknowledge acceptance/signing of these changes by Investigator.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Clarification Forms\nData Query Forms\nDocumentation of Corrections to Entered Data ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "\n4.9.3\n8.3.15",
        "ISO 14155 Reference (Device Studies)": "E.2.18 7.8.2 a     9.2.4.5 j    \n10.6 j",
        "Unique ID Number": 190,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.02,
        "Section Name": "Data Capture",
        "Artifact #": "10.02.05",
        "Artifact name": "Final Subject Data",
        "Definition / Purpose": "Final Subject data (EDC/ePRO/Paper) for the protocol and a copy of each site's data by-subject. Associated documents may include but are not limited to documentation of subject data corrections, subject diaries, questionnaires, laboratory reports and other third-party specialty data. Does not include the final study datasets.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Subject Data\nSite Receipt of Final Subject Data\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.9.3\n5.5\n8.3.14\n4.9.4",
        "ISO 14155 Reference (Device Studies)": "E.2.16     7.3        7.8.1\n7.8.2     9.2.4.5.j)\n10.6 j",
        "Unique ID Number": 191,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.01",
        "Artifact name": "Database  Requirements",
        "Definition / Purpose": "To provide a detailed design framework for the system(s) used to manage and store subject/patient data captured via a paper CRF or eCRF for the specified trial. Not to be confused with specifications for the Electronic Data Capture (EDC) system (see 10.04.02)",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Database Requirements\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "1.46\n5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.3",
        "Unique ID Number": 192,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 3,
        "Process Name": "Develop Study Design / Capture Subject Data",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.02",
        "Artifact name": "Edit Check Plan",
        "Definition / Purpose": "Specifications which will detect data that is illogical, unexpected, missing, redundant, or is outside of defined study parameters; usually implemented via programming logic",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Edit Check Plan\nEdit Check Specifications\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.3d",
        "Unique ID Number": 193,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.03",
        "Artifact name": "Edit Check Programming ",
        "Definition / Purpose": "The computer code which satisfies the edit check plan/specification details; may include a reference to where the code resides.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Edit Check Programming ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.3 a",
        "Unique ID Number": 194,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 3,
        "Process Name": "Develop Study Design / Capture Subject Data",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.04",
        "Artifact name": "Edit Check Testing ",
        "Definition / Purpose": "To provide evidence that the data edit checks have been implemented correctly; can include the data used to test the programming logic ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Edit Check Testing ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.3 f",
        "Unique ID Number": 195,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.05",
        "Artifact name": "Approval for Database Activation ",
        "Definition / Purpose": "Documentation that all database specification requirements have been satisfied and system can go live; will also include confirmation that UAT (user acceptance testing) has been successfully completed. May include a modified version to activate implementation of change control",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Approval for Database Activation ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "A.8 B    7.8.3",
        "Unique ID Number": 196,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Approval Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.06",
        "Artifact name": "External Data Transfer Specifications ",
        "Definition / Purpose": "To document import and export data specifications; includes but is not limited to diary, lab, IVRS, imaging; integration from external systems to database and may include transfer from one group to another.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "External Data Transfer Authorization\nExternal Data Transfer Specifications \nExternal Data Transfer Testing Documentation\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "A.8 B     3.13",
        "Unique ID Number": 197,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.07",
        "Artifact name": "Data Entry Guidelines (Paper)",
        "Definition / Purpose": "To provide detailed instructions on how CRF data is to be entered into a database; specific to a paper CRF trial (therefore, would not be required with an EDC trial).",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Entry Guidelines (Paper)",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.2",
        "Unique ID Number": 198,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 3,
        "Process Name": "Develop Study Design / Capture Subject Data",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.08",
        "Artifact name": "SAE Reconciliation ",
        "Definition / Purpose": "To document reconciliation and resolution of discrepancies between the SAEs in the safety and the clinical databases has been successfully completed.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "SAE Reconciliation \nSAE Reconciliation Approval\nSAE Reconciliation Report\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "9.2.5  7.8.3",
        "Unique ID Number": 199,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.09",
        "Artifact name": "Dictionary Coding ",
        "Definition / Purpose": "To document the tools used in medical coding and the final coded terms; includes medical sign off of coding; may include resolution discrepancies.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Dictionary Coding \nMedical Coding Approval                                                                                             \nMedical Coding Consistency Report                                                                        \nMedical Coding Guidelines\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "Unique ID Number": 200,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.10",
        "Artifact name": "Data Review Documentation",
        "Definition / Purpose": "To describe the procedures for creating and implementing a Quality Control (QC) Plan or Data Review Plan to ensure that quality data is captured into a clinical database on an ongoing basis. Artifact can include any evidence of the results from the plan.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Review Documentation\nData Review Plan \nData Validation Plan        \nDB Audit Specification\nThird Party Vendor Reconciliation Report       \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.3.d",
        "Unique ID Number": 201,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.11",
        "Artifact name": "Database Lock and Unlock Approval ",
        "Definition / Purpose": "Confirmation that all of the requirements for database release have been meet; may include all unlock and re-lock documentation as well as a report on data quality issues and summary of essential activities prior to database lock",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Database Interim Lock Approval\nDatabase Lock and Approval \nDatabase Lock and Unlock Approval \nDatabase Unlock Approval \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.3.a",
        "Unique ID Number": 202,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "08 Database Lock",
        "Dating Convention": "Approval Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.03,
        "Section Name": "Database",
        "Artifact #": "10.03.12",
        "Artifact name": "Database Change Control ",
        "Definition / Purpose": "Summary of requested change, reason for change, relevant approvals, impact / risk analysis, associated requirements, specifications and other documentation describing the validation and implementation of this change. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Database Change Control \nData Model Difference Report\nDatabase Modification Approval",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.3.a",
        "Unique ID Number": 244,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Change Control Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.04,
        "Section Name": "EDC Management",
        "Artifact #": "10.04.01",
        "Artifact name": "System Account Management",
        "Definition / Purpose": "To capture account management details for all users who received access to the system (e.g.: ePRO, eCRF); intended to include users' security role, date account granted, date account disabled.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "EDC User Authorization Documentation\nEDC User Report\nElectronic Signature Authorization Form\nSystem Account Management\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.3 (d) and (e)",
        "ISO 14155 Reference (Device Studies)": "7.8.3. h",
        "Unique ID Number": 204,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "09 Close-out Monitoring Visit / Site Closed",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.04,
        "Section Name": "EDC Management",
        "Artifact #": "10.04.02",
        "Artifact name": "Technical Design Document",
        "Definition / Purpose": "A technical planning and tracking document containing all the elements required to build and test the EDC application including the variables to be collected, their logical arrangement, navigation between the different forms, and the checks for logical consistency. May take the form of a spreadsheet created manually by a programmer and uploaded to the EDC application (e.g. to generate the eCRF or ePRO system), or exported from the application after building as a record of its technical design. May include some code for 10.03.03, Edit Check Programming.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Technical Design Document",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.3 ",
        "ISO 14155 Reference (Device Studies)": "7.8.3.b",
        "Unique ID Number": 245,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.04,
        "Section Name": "EDC Management",
        "Artifact #": "10.04.03",
        "Artifact name": "Validation Documentation",
        "Definition / Purpose": "Documents establishing the project context and documentation requirements for EDC (e.g.: eCRF or ePRO); can include the plan for and results of, the user acceptance testing (UAT). Includes the validation report to provide wrap up and post go-live summary if required.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Validation Certificate\nValidation Executed Scripts\nValidation  Plan\nValidation Report\nOther Validation Documents",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.5.1\n5.5.3 ",
        "ISO 14155 Reference (Device Studies)": "7.8.3.c",
        "Unique ID Number": 246,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 16,
        "Process Name": "Set up site(s)",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.05,
        "Section Name": "General",
        "Artifact #": "10.05.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E 2.11  9.2.3 c \n9.2.4.5 o    10.6.h\n",
        "Unique ID Number": 205,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.05,
        "Section Name": "General",
        "Artifact #": "10.05.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information\n\n",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 206,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.05,
        "Section Name": "General",
        "Artifact #": "10.05.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 207,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 10,
        "Zone Name": "Data Management",
        "Section #": 10.05,
        "Section Name": "General",
        "Artifact #": "10.05.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 208,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "11 Ongoing",
        "Site Level Document": "X",
        "Site Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.01,
        "Section Name": "Statistics Oversight",
        "Artifact #": "11.01.01",
        "Artifact name": "Statistical Analysis Plan ",
        "Definition / Purpose": "To describe the statistical aspects of the trial design, the process of data selection for all analyzes, the data items to be analyzed and all the procedures and methods to be employed in the analysis of those data items as well as the planned presentation of those results (Tables, Listings and Figures (TLFs), all versions of the SAP and approval forms). Includes interim and final.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Analysis Convention Document\nInterim Analysis SAP\nSAP Approval\nSPP Approval\nStatistical Analysis Plan (SAP)\nStatistical Programming Plan (SPP)",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": 6.9,
        "ISO 14155 Reference (Device Studies)": 6.6,
        "Artifact name in v1.3 EDM Reference Model": "Statistical Analysis Plan ",
        "Unique ID Number": 209,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.01,
        "Section Name": "Statistics Oversight",
        "Artifact #": "11.01.02",
        "Artifact name": "Sample Size Calculation",
        "Definition / Purpose": "To document the technique, assumptions and output used to calculate the sample size; can include QC and sign off.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Sample Size Calculation\nSample Size Validation",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "3.25       A7e             A7e6    6.2.2        E.2",
        "Unique ID Number": 210,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "01 First Country RA Approval",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.02,
        "Section Name": "Randomization",
        "Artifact #": "11.02.01",
        "Artifact name": "Randomization Plan ",
        "Definition / Purpose": "To describe the randomization scheme (e.g. number and name of treatments, strata, block size) and how the randomization will be carried out; this plan is then used to initiate programming.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Randomization Plan ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "4.7\n6.4.2",
        "Artifact name in v1.3 EDM Reference Model": "Randomization Scheme",
        "Unique ID Number": 211,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.02,
        "Section Name": "Randomization",
        "Artifact #": "11.02.02",
        "Artifact name": "Randomization Procedure ",
        "Definition / Purpose": "To define the actual steps for how subjects are randomized in a trial. This could be by interactive response technology (IRT)/IVRS, or a manual process ((i.e. work instruction). May be part of the randomization plan.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Randomization Procedure \nRandomization Specification\n\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 212,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "03 Site Live / Ready / Open for Enrollment",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.02,
        "Section Name": "Randomization",
        "Artifact #": "11.02.03",
        "Artifact name": "Master Randomization List ",
        "Definition / Purpose": "The single source on the assignment of subjects to protocol specified groups.  In blinded studies, this list remains blinded until its release following the final data lock.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Master Randomization List ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.2.18",
        "ISO 14155 Reference (Device Studies)": "E.1.19   7.8.1",
        "Unique ID Number": 213,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Country/ Region Level Document": "X",
        "Country Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.02,
        "Section Name": "Randomization",
        "Artifact #": "11.02.04",
        "Artifact name": "Randomization Programming ",
        "Definition / Purpose": "Computer code to generate randomization number for treatment assignment.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Randomization Programming ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.4.1",
        "ISO 14155 Reference (Device Studies)": "A.7.E     7.8.3",
        "Unique ID Number": 214,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.02,
        "Section Name": "Randomization",
        "Artifact #": "11.02.05",
        "Artifact name": "Randomization Sign Off",
        "Definition / Purpose": "To verify that the randomization program generates the randomization number and treatment assignment correctly according to the randomization schema specified for the trial.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Randomization Sign Off",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1.1",
        "ISO 14155 Reference (Device Studies)": "A.7.E   7.8.3.",
        "Unique ID Number": 215,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "02 Clinical Infrastructure Ready",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.02,
        "Section Name": "Randomization",
        "Artifact #": "11.02.06",
        "Artifact name": "End of Trial or Interim Unblinding",
        "Definition / Purpose": "To document and authorize the release of the randomization code and allow the trial data to be unblinded. Includes evidence of release of end of trial unblinding. May include a request for partial unblinding, or to open the randomization list for maintenance by randomization management personnel.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Administrative Interim Unblinding Request Form\nEnd of Trial or Interim Unblinding\nResults Release Authorization Memorandum           \n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "7.8.1  10.7.e",
        "Unique ID Number": 216,
        "Sponsor Document": "X",
        "Investigator Document": "X",
        "NaN": "D",
        "Process Number": 30,
        "Process Name": "Manage Subject Risk / Break Blind",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Signature Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.01",
        "Artifact name": "Data Definitions for Analysis Datasets",
        "Definition / Purpose": "To define the programming logic required to transform the raw dataset to the analysis dataset; includes populations, etc.; as outlined in the SAP.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Data Definitions for Analysis Datasets\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "Unique ID Number": 217,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.02",
        "Artifact name": "Analysis QC Documentation",
        "Definition / Purpose": "To confirm the QC procedures for analysis programs and validation of analysis QC programs, as well as the actual output of the QC steps.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Analysis QC Documentation\nValidation Documentation Approval                                                    \nValidation Plan                                                        \nValidation Report                                                       \n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "Unique ID Number": 218,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 12,
        "Process Name": "Develop Trial Management Strategy",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.03",
        "Artifact name": "Interim Analysis Raw Datasets ",
        "Definition / Purpose": "The export of raw data for interim analysis purposes. This may include CDISC datasets such as Operational Data Model (ODM) or SDTM.  ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Analysis Raw Datasets ",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "Unique ID Number": 219,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 36,
        "Process Name": "Analyze Data / Interim Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "File Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.04",
        "Artifact name": "Interim Analysis Programs",
        "Definition / Purpose": "The suite of programs designed to generate the interim analysis outputs as referenced in the SAP.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Analysis Programs\nInterim Analysis Datasets Programs\nInterim Analysis Macros\n\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 220,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "File Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.05",
        "Artifact name": "Interim Analysis Datasets ",
        "Definition / Purpose": "The datasets used for the interim analyses. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Analysis Datasets ",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 221,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 36,
        "Process Name": "Analyze Data / Interim Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "File Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.06",
        "Artifact name": "Interim Analysis Output",
        "Definition / Purpose": "The Tables Listings and Figures produced from the interim analysis datasets; includes Statistics approval.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Analysis Graphs\nInterim Analysis Figures\nInterim Analysis Listings\nInterim Analysis Statistics Approval\nInterim Analysis Tables",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 222,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 36,
        "Process Name": "Analyze Data / Interim Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.07",
        "Artifact name": "Final Analysis Raw Datasets ",
        "Definition / Purpose": "The export of raw data for final analysis purposes. This may include CDISC datasets such as Operational Data Model (ODM), SDTM or case report tabulation (CRT) package",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Analysis Raw Datasets",
        "Core or Recommended for inclusion": "Core",
        "Artifact name in v1.3 EDM Reference Model": "Datasets",
        "Unique ID Number": 223,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 37,
        "Process Name": "Analyze Data / Final Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "File Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.08",
        "Artifact name": "Final Analysis Programs",
        "Definition / Purpose": "The suite of programs designed to generate the final analysis outputs as referenced in the SAP.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Analysis Datasets Programs\nFinal Analysis Macros\nFinal Analysis Programs\n\n",
        "Core or Recommended for inclusion": "Core",
        "ISO 14155 Reference (Device Studies)": "D.6.I.",
        "Artifact name in v1.3 EDM Reference Model": "Program File for Analysis Dataset",
        "Unique ID Number": 224,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 4,
        "Process Name": "Develop Study Design / Document Development",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "File Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.09",
        "Artifact name": "Final Analysis Datasets",
        "Definition / Purpose": "The datasets used for the final analysis/case report tabulation (CRT) package. If required, study-level submission datasets can be filed here. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Analysis Datasets\n",
        "Core or Recommended for inclusion": "Core",
        "Artifact name in v1.3 EDM Reference Model": "Analysis Datasets",
        "Unique ID Number": 225,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 37,
        "Process Name": "Analyze Data / Final Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "File Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.10",
        "Artifact name": "Final Analysis Output",
        "Definition / Purpose": "The Tables, Listings and Figures produced from the final analysis datasets; includes Statistics approval. May be appended to the CSR.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Analysis Graphs\nFinal Analysis Figures\nFinal Analysis Listings\nFinal Analysis Statistics Approval\nFinal Analysis Tables",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.22\n8.4.8",
        "ISO 14155 Reference (Device Studies)": 8.4,
        "Artifact name in v1.3 EDM Reference Model": "Statistical Output",
        "Unique ID Number": 226,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 37,
        "Process Name": "Analyze Data / Final Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Document Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.03,
        "Section Name": "Analysis",
        "Artifact #": "11.03.11",
        "Artifact name": "Subject Evaluability Criteria and Subject Classification",
        "Definition / Purpose": "To document the decisions which define the criteriaapplied to evaluate each subject in the trial, in order to that will unambiguously assign the subject to the populations established in the SAP. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Final Protocol Deviation Report\nPopulation Definition Criteria\nProtocol Deviation Listing\nSubject Evaluability Criteria and Subject Classification\n\n",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "6.9.7",
        "ISO 14155 Reference (Device Studies)": "A.6.3",
        "Artifact name in v1.3 EDM Reference Model": "Protocol Deviation Listing",
        "Unique ID Number": 227,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "M",
        "Process Number": 36,
        "Process Name": "Analyze Data / Interim Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "08 Database Lock",
        "Dating Convention": "Version Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.04,
        "Section Name": "Report",
        "Artifact #": "11.04.01",
        "Artifact name": "Interim Statistical Report(s)",
        "Definition / Purpose": "To summarize the relevant statistical aspects of the interim analysis. May be appended to the CSR.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Interim Statistical Report(s)",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "E.3.8       8.3\n9.2.6 b\nAnnex D",
        "Unique ID Number": 228,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 40,
        "Process Name": "Report Data / Write Reports",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "05 Significant Study Event",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.04,
        "Section Name": "Report",
        "Artifact #": "11.04.02",
        "Artifact name": "Statistical Report",
        "Definition / Purpose": "To summarize the relevant statistical aspects of the final analysis. May be appended to the CSR. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Statistical Report",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "5.1\n5.5",
        "ISO 14155 Reference (Device Studies)": "E.3.8          8.3\n9.2.6 b\nAnnex D",
        "Artifact name in v1.3 EDM Reference Model": "Statistical Report",
        "Unique ID Number": 229,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 37,
        "Process Name": "Analyze Data / Final Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "10 Final Report / Clinical Study Report Approved",
        "Dating Convention": "Report Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.05,
        "Section Name": "General",
        "Artifact #": "11.05.01",
        "Artifact name": "Relevant Communications",
        "Definition / Purpose": "Zone-specific agreements, significant discussions or relevant information, but not specifically listed in this Reference Model. Types of correspondence may include, but not limited to: letters, memo, electronic communications and faxes.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Relevant Communications",
        "Core or Recommended for inclusion": "Core",
        "ICH Code": "8.3.11",
        "ISO 14155 Reference (Device Studies)": "E2.11    9.2.3 c \n9.2.4.5 o    10.6.h\n",
        "Unique ID Number": 230,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": "Per content",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Correspondence Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.05,
        "Section Name": "General",
        "Artifact #": "11.05.02",
        "Artifact name": "Tracking Information",
        "Definition / Purpose": "Zone-specific documents developed for the purpose of tracking activities during the course of the trial. ",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Tracking Information",
        "Core or Recommended for inclusion": "Recommended",
        "Unique ID Number": 231,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 21,
        "Process Name": "Manage Project / Report on Progress",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Last Entry Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.05,
        "Section Name": "General",
        "Artifact #": "11.05.03",
        "Artifact name": "Meeting Material",
        "Definition / Purpose": "Agenda, presentation materials and other documentation generated during an internal or external zone-related meeting which documents any agreements or significant discussions. Includes meeting minutes or Q&A, attendance sheets and any pre-meeting material.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Agenda\nAttendance Sheet\nMinutes\nPresentation Materials\n",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 232,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 37,
        "Process Name": "Analyze Data / Final Data Analysis",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Meeting Start Date"
    },
    {
        "Zone #": 11,
        "Zone Name": "Statistics",
        "Section #": 11.05,
        "Section Name": "General",
        "Artifact #": "11.05.04",
        "Artifact name": "Filenote",
        "Definition / Purpose": "To document any decision or to clarify any information relating to this zone.",
        "Recommended Subartifacts -  Documents/documentation recommended to be filed to the artifact.": "Filenote",
        "Core or Recommended for inclusion": "Core",
        "Unique ID Number": 233,
        "Sponsor Document": "X",
        "Investigator Document": "NO",
        "NaN": "D",
        "Process Number": 20,
        "Process Name": "Manage Project",
        "Trial Level Document ": "X",
        "Trial Level MILESTONE/EVENT": "11 Ongoing",
        "Dating Convention": "Filenote Date"
    }
]